12924226
apa
50
desc
year
1
1
561
https://dida.nagasaki-u.ac.jp/dida_wp/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-bc9b7672cd8f286953b42dff2090031f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22QSU26UXL%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Kapandji%2C%20M.%2C%20Wada%2C%20A.%2C%20Yamamoto%2C%20K.%2C%20Dumre%2C%20S.%20P.%2C%20Nwe%2C%20K.%20M.%2C%20Lin%2C%20H.%2C%20Takamatsu%2C%20Y.%2C%20Thant%2C%20K.%20Z.%2C%20Thu%2C%20H.%20M.%2C%20Urano%2C%20T.%2C%20Pandey%2C%20B.%20D.%2C%20%26amp%3B%20Morita%2C%20K.%20%282024%29.%20Performance%20of%20Fujifilm%20Dengue%20NS1%20Antigen%20Rapid%20Diagnosis%20Kit%20Compared%20to%20Quantitative%20Real-Time%20Polymerase%20Chain%20Reaction.%20%3Ci%3EPathogens%3C%5C%2Fi%3E%2C%20%3Ci%3E13%3C%5C%2Fi%3E%289%29%2C%20818.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fpathogens13090818%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fpathogens13090818%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DQSU26UXL%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Performance%20of%20Fujifilm%20Dengue%20NS1%20Antigen%20Rapid%20Diagnosis%20Kit%20Compared%20to%20Quantitative%20Real-Time%20Polymerase%20Chain%20Reaction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merveille%22%2C%22lastName%22%3A%22Kapandji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atsuhiko%22%2C%22lastName%22%3A%22Wada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ko%22%2C%22lastName%22%3A%22Yamamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%20Prakash%22%2C%22lastName%22%3A%22Dumre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khine%20Mya%22%2C%22lastName%22%3A%22Nwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Htin%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyaw%20Zin%22%2C%22lastName%22%3A%22Thant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hlaing%20Myat%22%2C%22lastName%22%3A%22Thu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basu%20Dev%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Dengue%20is%20a%20viral%20infection%20caused%20by%20the%20dengue%20virus%20%28DENV%29%2C%20transmitted%20to%20humans%20through%20the%20bite%20of%20infected%20Aedes%20mosquitoes.%20About%20half%20of%20the%20world%5Cu2019s%20population%20is%20now%20at%20risk%20of%20dengue%2C%20which%20represents%20a%20global%20public%20health%20concern%2C%20especially%20in%20tropical%20and%20subtropical%20countries.%20Early%20detection%20of%20the%20viral%20infection%20is%20crucial%20to%20manage%20the%20disease%3B%20hence%2C%20effective%20rapid%20diagnostic%20tests%20are%20essential.%20In%20this%20study%2C%20we%20evaluated%20the%20performance%20between%20the%20new%20Fujifilm%20Dengue%20non-structural%20antigen%20diagnosis%20kit%20%28FF%20NS1%20kit%29%20and%20the%20SD%20Bioline%20NS1%20antigen%20test%20kit%20%28SD%20NS1%20kit%29%20against%20the%20quantitative%20real-time%20polymerase%20chain%20reaction%20%28qRT-PCR%29%20assays.%20The%20140%20acute%20serum%20samples%20collected%20from%20the%20Yangon%20General%20Hospital%20and%20Yangon%20Children%5Cu2019s%20Hospital%2C%20Myanmar%2C%20from%202017%20to%202019%20were%20characterised%20by%20the%20three%20assays.%20With%20the%20qRT-PCR%20as%20the%20standard%2C%20the%20FF%20NS1%20kit%20and%20the%20SD%20NS1%20kit%20exhibited%20sensitivity%20of%2094.3%25%20and%2088.6%25%2C%20respectively%2C%20and%20specificity%20of%20100%25%20in%20both%20kits.%20Moreover%2C%20the%20positivity%20rates%20of%20the%20FF%20NS1%20kit%20and%20the%20SD%20NS1%20kit%20were%2097.5%25%20and%2095%25%20in%20primary%20infection%20and%2090%25%20and%2080%25%20in%20secondary%20infection%2C%20respectively.%20Our%20overall%20results%20suggest%20that%20the%20FF%20NS1%20kit%20is%20reliable%20and%20accurate%20for%20detecting%20DENV%20infection.%22%2C%22date%22%3A%222024-09-23%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fpathogens13090818%22%2C%22ISSN%22%3A%222076-0817%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2076-0817%5C%2F13%5C%2F9%5C%2F818%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-10-01T04%3A42%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22QACRDTJZ%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kulma%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKulma%2C%20I.%2C%20Na-Bangchang%2C%20K.%2C%20Carvallo%20Herrera%2C%20A.%2C%20Ndubuisi%2C%20I.%20T.%2C%20Iwasaki%2C%20M.%2C%20Tomono%2C%20H.%2C%20Morita%2C%20C.%20T.%2C%20Okamura%2C%20H.%2C%20Mukae%2C%20H.%2C%20%26amp%3B%20Tanaka%2C%20Y.%20%282024%29.%20Analysis%20of%20the%20Effector%20Functions%20of%20V%26%23x3B4%3B2%20%26%23x3B3%3B%26%23x3B4%3B%20T%20Cells%20and%20NK%20Cells%20against%20Cholangiocarcinoma%20Cells.%20%3Ci%3ECells%3C%5C%2Fi%3E%2C%20%3Ci%3E13%3C%5C%2Fi%3E%2816%29%2C%201322.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcells13161322%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcells13161322%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DQACRDTJZ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Analysis%20of%20the%20Effector%20Functions%20of%20V%5Cu03b42%20%5Cu03b3%5Cu03b4%20T%20Cells%20and%20NK%20Cells%20against%20Cholangiocarcinoma%20Cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inthuon%22%2C%22lastName%22%3A%22Kulma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kesara%22%2C%22lastName%22%3A%22Na-Bangchang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Carvallo%20Herrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ifeanyi%20Theodora%22%2C%22lastName%22%3A%22Ndubuisi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masashi%22%2C%22lastName%22%3A%22Iwasaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiromi%22%2C%22lastName%22%3A%22Tomono%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Craig%20T.%22%2C%22lastName%22%3A%22Morita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haruki%22%2C%22lastName%22%3A%22Okamura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroshi%22%2C%22lastName%22%3A%22Mukae%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshimasa%22%2C%22lastName%22%3A%22Tanaka%22%7D%5D%2C%22abstractNote%22%3A%22Cholangiocarcinoma%20%28CCA%29%20is%20a%20rare%20disease%20characterized%20by%20malignant%20cells%20derived%20from%20the%20epithelial%20cells%20of%20the%20biliary%20duct%20system.%20Despite%20extensive%20treatments%2C%20the%20prognosis%20for%20CCA%20remains%20poor%2C%20emphasizing%20the%20critical%20need%20for%20the%20development%20of%20novel%20treatments.%20Considerable%20attention%20has%20been%20directed%20towards%20innate%20immune%20effector%20cells%2C%20which%20can%20recognize%20tumor%20cells%20independently%20of%20the%20major%20histocompatibility%20complex%2C%20laying%20the%20foundation%20for%20the%20development%20of%20off-the-shelf%20drugs.%20In%20this%20study%2C%20we%20cultured%20innate%20immune%20cells%20obtained%20from%20the%20peripheral%20blood%20of%20healthy%20adults%20and%20conducted%20a%20comparative%20analysis%20of%20the%20effector%20functions%20against%20CCA%20cell%20lines%20by%20V%5Cu03b42%20%5Cu03b3%5Cu03b4%20T%20cells%20and%20NK%20cells.%20This%20analysis%20was%20performed%20using%20standard%20short-%20and%20long-term%20cytotoxicity%20assays%2C%20as%20well%20as%20ELISA%20for%20IFN-%5Cu03b3.%20V%5Cu03b42%20%5Cu03b3%5Cu03b4%20T%20cells%20demonstrated%20cytotoxicity%20and%20IFN-%5Cu03b3%20production%20in%20response%20to%20CCA%20cells%20in%20a%20TCR-dependent%20manner%2C%20particularly%20in%20the%20presence%20of%20tetrakis-pivaloyloxymethyl%202-%28thiazole-2-ylamino%29ethylidene-1%2C1-bisphosphonate%2C%20a%20bisphosphonate%20prodrug.%20In%20contrast%2C%20direct%20killing%20and%20antibody-dependent%20cellular%20cytotoxicity%20were%20relatively%20slow%20and%20weak.%20Conversely%2C%20NK%20cells%20displayed%20potent%2C%20direct%20cytotoxicity%20against%20CCA%20cells.%20In%20summary%2C%20both%20V%5Cu03b42%20%5Cu03b3%5Cu03b4%20T%20cells%20and%20NK%20cells%20show%20promise%20as%20innate%20immune%20effector%20cells%20for%20adoptive%20transfer%20therapy%20in%20the%20context%20of%20CCA.%22%2C%22date%22%3A%222024-08-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fcells13161322%22%2C%22ISSN%22%3A%222073-4409%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-09-02T00%3A17%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22GRDJZQKB%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ondo%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-28%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EOndo%2C%20G.%2C%20Ushijima%2C%20Y.%2C%20Abe%2C%20H.%2C%20Mahmoudou%2C%20S.%2C%20Bikangui%2C%20R.%2C%20Nkoma%2C%20A.%2C%20Mbadinga%2C%20M.%2C%20More%2C%20A.%2C%20Agbanrin%2C%20M.%2C%20Pemba%2C%20C.%2C%20Beh%20Mba%2C%20R.%2C%20Adegnika%2C%20A.%20A.%2C%20Lell%2C%20B.%2C%20%26amp%3B%20Yasuda%2C%20J.%20%282024%29.%20Genetic%20Diversity%20and%20Detection%20of%20Respiratory%20Viruses%20Excluding%20SARS-CoV-2%20during%20the%20COVID-19%20Pandemic%20in%20Gabon%2C%202020%26%23x2013%3B2021.%20%3Ci%3EViruses%3C%5C%2Fi%3E%2C%20%3Ci%3E16%3C%5C%2Fi%3E%285%29%2C%20698.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv16050698%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv16050698%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DGRDJZQKB%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genetic%20Diversity%20and%20Detection%20of%20Respiratory%20Viruses%20Excluding%20SARS-CoV-2%20during%20the%20COVID-19%20Pandemic%20in%20Gabon%2C%202020%5Cu20132021%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgelin%22%2C%22lastName%22%3A%22Ondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuri%22%2C%22lastName%22%3A%22Ushijima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haruka%22%2C%22lastName%22%3A%22Abe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sa%5Cu00efdou%22%2C%22lastName%22%3A%22Mahmoudou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigue%22%2C%22lastName%22%3A%22Bikangui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Nkoma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marien%22%2C%22lastName%22%3A%22Mbadinga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayong%22%2C%22lastName%22%3A%22More%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maradona%22%2C%22lastName%22%3A%22Agbanrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Pemba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romuald%22%2C%22lastName%22%3A%22Beh%20Mba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayola%20Akim%22%2C%22lastName%22%3A%22Adegnika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bertrand%22%2C%22lastName%22%3A%22Lell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiro%22%2C%22lastName%22%3A%22Yasuda%22%7D%5D%2C%22abstractNote%22%3A%22Acute%20respiratory%20infections%20are%20a%20major%20global%20burden%20in%20resource-limited%20countries%2C%20including%20countries%20in%20Africa.%20Although%20COVID-19%20has%20been%20well%20studied%20since%20the%20pandemic%20emerged%20in%20Gabon%2C%20Central%20Africa%2C%20less%20attention%20has%20been%20paid%20to%20other%20respiratory%20viral%20diseases%2C%20and%20very%20little%20data%20are%20available.%20Herein%2C%20we%20provide%20the%20first%20data%20on%20the%20genetic%20diversity%20and%20detection%20of%2018%20major%20respiratory%20viruses%20in%20Gabon%20during%20the%20COVID-19%20pandemic.%20Of%20582%20nasopharyngeal%20swab%20specimens%20collected%20from%20March%202020%20to%20July%202021%2C%20which%20were%20SARS-CoV-2%20negative%2C%20156%20were%20positive%20%2826%25%29%20for%20the%20following%20viruses%3A%20enterovirus%20%2820.3%25%29%2C%20human%20rhinovirus%20%28HRV%29%20%284.6%25%29%2C%20human%20coronavirus%20OC43%20%281.2%25%29%2C%20human%20adenovirus%20%280.9%25%29%2C%20human%20metapneumovirus%20%28hMPV%29%20%280.5%25%29%2C%20influenza%20A%20virus%20%28IAV%29%20%280.3%25%29%2C%20and%20human%20parainfluenza%20viruses%20%280.5%25%29.%20To%20determine%20the%20genetic%20diversity%20and%20transmission%20route%20of%20the%20viruses%2C%20phylogenetic%20analyses%20were%20performed%20using%20genome%20sequences%20of%20the%20detected%20viruses.%20The%20IAV%20strain%20detected%20in%20this%20study%20was%20genetically%20similar%20to%20strains%20isolated%20in%20the%20USA%2C%20whereas%20the%20hMPV%20strain%20belonging%20to%20the%20A2b%20subtype%20formed%20a%20cluster%20with%20Kenyan%20strains.%20This%20study%20provides%20the%20first%20complete%20genomic%20sequences%20of%20HRV%2C%20IAV%2C%20and%20hMPV%20detected%20in%20Gabon%2C%20and%20provides%20insight%20into%20the%20circulation%20of%20respiratory%20viruses%20in%20the%20country.%22%2C%22date%22%3A%222024-04-28%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fv16050698%22%2C%22ISSN%22%3A%221999-4915%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1999-4915%5C%2F16%5C%2F5%5C%2F698%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-08-01T06%3A08%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22V8F4WA58%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hoa-Tran%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-29%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHoa-Tran%2C%20T.%20N.%2C%20Nakagomi%2C%20T.%2C%20Vu%2C%20H.%20M.%2C%20Nguyen%2C%20T.%20T.%20T.%2C%20Dao%2C%20A.%20T.%20H.%2C%20Nguyen%2C%20A.%20T.%2C%20Bines%2C%20J.%20E.%2C%20Thomas%2C%20S.%2C%20Grabovac%2C%20V.%2C%20Kataoka-Nakamura%2C%20C.%2C%20Taichiro%2C%20T.%2C%20Hasebe%2C%20F.%2C%20Kodama%2C%20T.%2C%20Kaneko%2C%20M.%2C%20Dang%2C%20H.%20T.%20T.%2C%20Duong%2C%20H.%20T.%2C%20Anh%2C%20D.%20D.%2C%20%26amp%3B%20Nakagomi%2C%20O.%20%282024%29.%20Evolution%20of%20DS-1-like%20G8P%5B8%5D%20rotavirus%20A%20strains%20from%20Vietnamese%20children%20with%20acute%20gastroenteritis%20%282014%26%23x2013%3B21%29%3A%20Adaptation%20and%20loss%20of%20animal%20rotavirus-derived%20%3Ci%3Egenes%3C%5C%2Fi%3E%20during%20human-to-human%20spread.%20%3Ci%3EVirus%20Evolution%3C%5C%2Fi%3E%2C%20%3Ci%3E10%3C%5C%2Fi%3E%281%29%2C%20veae045.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fve%5C%2Fveae045%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fve%5C%2Fveae045%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DV8F4WA58%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evolution%20of%20DS-1-like%20G8P%5B8%5D%20rotavirus%20A%20strains%20from%20Vietnamese%20children%20with%20acute%20gastroenteritis%20%282014%5Cu201321%29%3A%20Adaptation%20and%20loss%20of%20animal%20rotavirus-derived%20%3Ci%3Egenes%3C%5C%2Fi%3E%20during%20human-to-human%20spread%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Nguyen%22%2C%22lastName%22%3A%22Hoa-Tran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toyoko%22%2C%22lastName%22%3A%22Nakagomi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hung%20Manh%22%2C%22lastName%22%3A%22Vu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trang%20Thu%20Thi%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anh%20Thi%20Hai%22%2C%22lastName%22%3A%22Dao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anh%20The%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20E%22%2C%22lastName%22%3A%22Bines%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varja%22%2C%22lastName%22%3A%22Grabovac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chikako%22%2C%22lastName%22%3A%22Kataoka-Nakamura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takemura%22%2C%22lastName%22%3A%22Taichiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Futoshi%22%2C%22lastName%22%3A%22Hasebe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toshio%22%2C%22lastName%22%3A%22Kodama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miho%22%2C%22lastName%22%3A%22Kaneko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huyen%20Thi%20Thanh%22%2C%22lastName%22%3A%22Dang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong%20Thi%22%2C%22lastName%22%3A%22Duong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dang%20Duc%22%2C%22lastName%22%3A%22Anh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Osamu%22%2C%22lastName%22%3A%22Nakagomi%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Animal%20rotaviruses%20A%20%28RVAs%29%20are%20considered%20the%20source%20of%20emerging%2C%20novel%20RVA%20strains%20that%20have%20the%20potential%20to%20cause%20global%20spread%20in%20humans.%20A%20case%20in%20point%20was%20the%20emergence%20of%20G8%20bovine%20RVA%20consisting%20of%20the%20P%5B8%5D%20VP4%20gene%20and%20the%20DS-1-like%20backbone%20genes%20that%20appeared%20to%20have%20jumped%20into%20humans%20recently.%20However%2C%20it%20was%20not%20well%20documented%20what%20evolutionary%20changes%20occurred%20on%20the%20animal%20RVA-derived%20genes%20during%20circulation%20in%20humans.%20Rotavirus%20surveillance%20in%20Vietnam%20found%20that%20DS-1-like%20G8P%5B8%5D%20strains%20emerged%20in%202014%2C%20circulated%20in%20two%20prevalent%20waves%2C%20and%20disappeared%20in%202021.%20This%20surveillance%20provided%20us%20with%20a%20unique%20opportunity%20to%20investigate%20the%20whole%20process%20of%20evolutionary%20changes%2C%20which%20occurred%20in%20an%20animal%20RVA%20that%20had%20jumped%20the%20host%20species%20barrier.%20Of%20the%20843%20G8P%5B8%5D%20samples%20collected%20from%20children%20with%20acute%20diarrhoea%20in%20Vietnam%20between%202014%20and%202021%2C%20fifty-eight%20strains%20were%20selected%20based%20on%20their%20distinctive%20electropherotypes%20of%20the%20genomic%20RNA%20identified%20using%20polyacrylamide%20gel%20electrophoresis.%20Whole-genome%20sequence%20analysis%20of%20those%20fifty-eight%20strains%20showed%20that%20the%20strains%20dominant%20during%20the%20first%20wave%20of%20prevalence%20%282014%5Cu201317%29%20carried%20animal%20RVA-derived%20VP1%2C%20NSP2%2C%20and%20NSP4%20genes.%20However%2C%20the%20strains%20from%20the%20second%20wave%20of%20prevalence%20%282018%5Cu201321%29%20lost%20these%20genes%2C%20which%20were%20replaced%20with%20cognate%20human%20RVA-derived%20genes%2C%20thus%20creating%20strain%20with%20G8P%5B8%5D%20on%20a%20fully%20DS-1-like%20human%20RVA%20gene%20backbone.%20The%20G8%20VP7%20and%20P%5B8%5D%20VP4%20genes%20underwent%20some%20point%20mutations%20but%20the%20phylogenetic%20lineages%20to%20which%20they%20belonged%20remained%20unchanged.%20We%2C%20therefore%2C%20propose%20a%20hypothesis%20regarding%20the%20tendency%20for%20the%20animal%20RVA-derived%20genes%20to%20be%20expelled%20from%20the%20backbone%20genes%20of%20the%20progeny%20strains%20after%20crossing%20the%20host%20species%20barrier.%20This%20study%20underlines%20the%20importance%20of%20long-term%20surveillance%20of%20circulating%20wild-type%20strains%20in%20order%20to%20better%20understand%20the%20adaptation%20process%20and%20the%20fate%20of%20newly%20emerging%2C%20animal-derived%20RVA%20among%20the%20human%20population.%20Further%20studies%20are%20warranted%20to%20disclose%20the%20molecular%20mechanisms%20by%20which%20spillover%20animal%20RVAs%20become%20readily%20transmissible%20among%20humans%2C%20and%20the%20roles%20played%20by%20the%20expulsion%20of%20animal-derived%20genes%20and%20herd%20immunity%20formed%20in%20the%20local%20population.%22%2C%22date%22%3A%222024-06-29%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1093%5C%2Fve%5C%2Fveae045%22%2C%22ISSN%22%3A%222057-1577%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fve%5C%2Farticle%5C%2Fdoi%5C%2F10.1093%5C%2Fve%5C%2Fveae045%5C%2F7697220%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-08-01T02%3A44%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22VG8TNDCH%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mogasale%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-28%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMogasale%2C%20V.%2C%20Sinha%2C%20A.%2C%20John%2C%20J.%2C%20Farooqui%2C%20H.%2C%20Ray%2C%20A.%2C%20Chantler%2C%20T.%2C%20Mogasale%2C%20V.%2C%20Dhoubhadel%2C%20B.%20G.%2C%20Edmunds%2C%20W.%20J.%2C%20Clark%2C%20A.%20D.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20%3Ci%3ETyphoid%20Conjugate%20Vaccine%20Implementation%20in%20India%3A%20A%20Review%20of%20Supportive%20Evidence%3C%5C%2Fi%3E%20%28SSRN%20Scholarly%20Paper%20No.%204870785%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4870785%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4870785%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DVG8TNDCH%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Typhoid%20Conjugate%20Vaccine%20Implementation%20in%20India%3A%20A%20Review%20of%20Supportive%20Evidence%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijayalaxmi%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anish%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Habib%22%2C%22lastName%22%3A%22Farooqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arindam%22%2C%22lastName%22%3A%22Ray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracey%22%2C%22lastName%22%3A%22Chantler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vittal%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhim%20Gopal%22%2C%22lastName%22%3A%22Dhoubhadel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20John%22%2C%22lastName%22%3A%22Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Typhoid%20conjugate%20vaccines%20are%20available%20in%20the%20private%20market%20in%20India%20and%20are%20also%20recommended%20by%20the%20National%20Technical%20Advisory%20Group%20on%20Immunisation%20for%20inclusion%20in%20the%20Universal%20Immunisation%20Programme%20in%202022%20to%20control%20and%20prevent%20typhoid%20fever.%20The%20aim%20of%20our%20study%20is%20to%20synthesise%20the%20supportive%20evidence%20for%20typhoid%20conjugate%20vaccine%20implementation%20in%20India.%20Methods%3A%20We%20conducted%20a%20literature%20review%20to%20identify%20supportive%20evidence%20for%20typhoid%20conjugate%20vaccine%20implementation%20in%20India%20based%20on%20the%20key%20criteria%20of%20the%20Evidence-to-Recommendation%20framework%20developed%20by%20the%20World%20Health%20Organisation%20for%20National%20Immunisation%20Technical%20Advisory%20Groups.%20Results%3A%20We%20synthesised%20credible%20evidence%20on%20the%20burden%20of%20typhoid%20disease%2C%20the%20benefits%20and%20safety%20of%20typhoid%20conjugate%20vaccine%2C%20cost-effectiveness%20analysis%2C%20and%20implementation%20feasibility.%20However%2C%20the%20evidence%20on%20budget%20impact%20analysis%2C%20vaccine%20demand%20and%20supply%20forecast%2C%20equity%20analysis%2C%20target%20population%20values%20and%20preferences%2C%20acceptability%20of%20immunisation%20service%20providers%2C%20in-country%20data%20on%20co-administration%20safety%2C%20and%20antimicrobial%20resistance%20tracking%20was%20limited.%20Conclusion%3A%20We%20identified%20and%20listed%20evidence%20gaps%20based%20on%20the%20literature%20review.%20We%20recommend%20identifying%20research%20priorities%20for%20supporting%20typhoid%20conjugate%20vaccine%20decision-making%20in%20India%20by%20combining%20evidence%20gaps%20with%20the%20perceived%20importance%20of%20the%20same%20evidence%20among%20immunisation%20stakeholders.%20Further%2C%20we%20recognised%20a%20need%20for%20a%20bivalent%20enteric%20fever%20vaccine%20in%20India%20and%20a%20lack%20of%20evidence%20demonstrating%20the%20potential%20public%20health%20value%20of%20these%20new%20bivalent%20vaccines%20in%20the%20pipeline.%22%2C%22genre%22%3A%22SSRN%20Scholarly%20Paper%22%2C%22repository%22%3A%22%22%2C%22archiveID%22%3A%224870785%22%2C%22date%22%3A%222024-03-28%22%2C%22DOI%22%3A%2210.2139%5C%2Fssrn.4870785%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpapers.ssrn.com%5C%2Fabstract%3D4870785%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-07-01T02%3A12%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22QIAA2HTB%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Murayama%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMurayama%2C%20H.%2C%20Endo%2C%20A.%2C%20%26amp%3B%20Yonekura%2C%20S.%20%282023%29.%20Estimation%20of%20waning%20vaccine%20effectiveness%20from%20population-level%20surveillance%20data%20in%20multi-variant%20epidemics.%20%3Ci%3EEpidemics%3C%5C%2Fi%3E%2C%20%3Ci%3E45%3C%5C%2Fi%3E%2C%20100726.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.epidem.2023.100726%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.epidem.2023.100726%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DQIAA2HTB%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimation%20of%20waning%20vaccine%20effectiveness%20from%20population-level%20surveillance%20data%20in%20multi-variant%20epidemics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroaki%22%2C%22lastName%22%3A%22Murayama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akira%22%2C%22lastName%22%3A%22Endo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shouto%22%2C%22lastName%22%3A%22Yonekura%22%7D%5D%2C%22abstractNote%22%3A%22Monitoring%20time-varying%20vaccine%20effectiveness%20%28e.g.%2C%20due%20to%20waning%20of%20immunity%20and%20the%20emergence%20of%20novel%20variants%29%20provides%20crucial%20information%20for%20outbreak%20control.%20Existing%20studies%20of%20time-varying%20vaccine%20effectiveness%20have%20used%20individual-level%20data%2C%20most%20importantly%20dates%20of%20vaccination%20and%20variant%20classification%2C%20which%20are%20often%20not%20available%20in%20a%20timely%20manner%20or%20from%20a%20wide%20range%20of%20population%20groups.%20We%20present%20a%20novel%20Bayesian%20framework%20for%20estimating%20the%20waning%20of%20variant-specific%20vaccine%20effectiveness%20in%20the%20presence%20of%20multi-variant%20circulation%20from%20population-level%20surveillance%20data.%20Applications%20to%20simulated%20outbreaks%20and%20the%20COVID-19%20epidemic%20in%20Japan%20are%20also%20presented.%20Our%20results%20show%20that%20variant-specific%20waning%20vaccine%20effectiveness%20estimated%20from%20population-level%20surveillance%20data%20could%20approximately%20reproduce%20the%20estimates%20from%20previous%20test-negative%20design%20studies%2C%20allowing%20for%20rapid%2C%20if%20crude%2C%20assessment%20of%20the%20epidemic%20situation%20before%20fine-scale%20studies%20are%20made%20available.%22%2C%22date%22%3A%222023-12-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.epidem.2023.100726%22%2C%22ISSN%22%3A%221755-4365%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1755436523000622%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-06-17T05%3A48%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22K7AEAQAJ%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Luvai%2C%20E.%20A.%20C.%2C%20Toizumi%2C%20M.%2C%20Moriuchi%2C%20M.%2C%20Takamatsu%2C%20Y.%2C%20Inoue%2C%20S.%2C%20Urano%2C%20T.%2C%20Bui%2C%20M.%20X.%2C%20Thai%20Hung%2C%20D.%2C%20Thi%20Nguyen%2C%20H.-A.%2C%20Anh%2C%20D.%20D.%2C%20Yoshida%2C%20L.-M.%2C%20Moriuchi%2C%20H.%2C%20%26amp%3B%20Morita%2C%20K.%20%282024%29.%20Possible%20vertical%20transmission%20of%20Chikungunya%20virus%20infection%20detected%20in%20the%20cord%20blood%20samples%20from%20a%20birth%20cohort%20in%20Vietnam.%20%3Ci%3EJournal%20of%20Infection%20and%20Public%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E17%3C%5C%2Fi%3E%286%29%2C%201050%26%23x2013%3B1056.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2024.04.012%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2024.04.012%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DK7AEAQAJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Possible%20vertical%20transmission%20of%20Chikungunya%20virus%20infection%20detected%20in%20the%20cord%20blood%20samples%20from%20a%20birth%20cohort%20in%20Vietnam%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20Ajema%20Chebichi%22%2C%22lastName%22%3A%22Luvai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michiko%22%2C%22lastName%22%3A%22Toizumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masako%22%2C%22lastName%22%3A%22Moriuchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minh%20Xuan%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Do%22%2C%22lastName%22%3A%22Thai%20Hung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hien-Anh%22%2C%22lastName%22%3A%22Thi%20Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dang%20Duc%22%2C%22lastName%22%3A%22Anh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lay-Myint%22%2C%22lastName%22%3A%22Yoshida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroyuki%22%2C%22lastName%22%3A%22Moriuchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnChikungunya%20virus%20%28CHIKV%29%20is%20an%20alphavirus%20%28genus%20Alphavirus%2C%20family%20Togaviridae%29%20that%20is%20primarily%20transmitted%20to%20humans%20by%20Aedes%20mosquitoes%2C%20and%20can%20be%20transmitted%20from%20mother%20to%20child.%20Little%20is%20known%20about%20CHIKV%20transmission%20in%20Vietnam%2C%20where%20dengue%20is%20endemic%20and%20Aedes%20mosquitoes%20are%20abundant.%20This%20study%20aimed%20to%20determine%20the%20prevalence%20and%20characteristics%20of%20vertical%20CHIKV%20infection%20in%20a%20birth%20cohort%2C%20and%20seroprevalence%20of%20anti-CHIKV%20antibodies%20with%20or%20without%20confirmation%20by%20neutralization%20tests%20among%20women%20bearing%20children%20in%20Vietnam.%5CnMethods%5CnWe%20collected%20umbilical%20cord%20blood%20plasma%20samples%20from%20each%20newly%20delivered%20baby%20in%20Nha%20Trang%2C%20Central%20Vietnam%2C%20between%20July%202017%20and%20September%202018.%20Samples%20were%20subjected%20to%20molecular%20assay%20%28quantitative%20real-time%20RT-PCR%29%20and%20serological%20tests%20%28anti-CHIKV%20IgM%20capture%20and%20IgG%20indirect%20enzyme-linked%20immunosorbent%20assay%2C%20and%20neutralization%20tests%29.%5CnResults%5CnOf%20the%202012%20tested%20cord%20blood%20samples%20from%20newly%20delivered%20babies%2C%20the%20CHIKV%20viral%20genome%20was%20detected%20in%206%20%280.3%25%29%20samples%20by%20RT-PCR%2C%20whereas%2C%2015%20samples%20%280.7%25%29%20were%20anti-CHIKV-IgM%20positive.%20Overall%2C%2018%20%280.9%25%2C%2095%25%20CI%3A%200.6%5Cu20131.5%29%20samples%2C%20including%20three%20positives%20for%20both%20CHIKV%20IgM%20and%20viral%20genome%20on%20RT-PCR%2C%20were%20regarded%20as%20vertical%20transmission%20of%20CHIKV%20infection.%20Of%20the%202012%20cord%20blood%20samples%2C%2010%20%280.5%25%2C%2095%25%20CI%3A%200.2%5Cu20130.9%29%20were%20positive%20for%20both%20anti-CHIKV%20IgM%20and%20IgG.%20Twenty-nine%20%281.4%25%2C%2095%25%20CI%3A%201.0%5Cu20132.1%29%20were%20seropositive%20for%20anti-CHIKV%20IgG%20while%2026%20%281.3%25%2C%2095%25%20CI%3A%200.8%5Cu20131.9%29%20of%20them%20were%20also%20positive%20for%20neutralizing%20antibodies%2C%20and%20regarded%20as%20seropositive%20with%20neutralization%20against%20CHIKV%20infection.%5CnConclusion%5CnThis%20is%20the%20first%20report%20of%20a%20possible%20CHIKV%20maternal-neonatal%20infection%20in%20a%20birth%20cohort%20in%20Vietnam.%20The%20findings%20indicate%20that%20follow-up%20and%20a%20differential%20diagnosis%20of%20CHIKV%20infection%20in%20pregnant%20women%20are%20needed%20to%20clarify%20the%20potential%20for%20CHIKV%20vertical%20transmission%20and%20its%20impact%20in%20the%20newborn.%22%2C%22date%22%3A%222024-06-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jiph.2024.04.012%22%2C%22ISSN%22%3A%221876-0341%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1876034124001254%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-06-17T05%3A48%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22EXMPAVZI%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Asakura%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAsakura%2C%20T.%20R.%2C%20Jung%2C%20S.%2C%20Murayama%2C%20H.%2C%20Ghaznavi%2C%20C.%2C%20Sakamoto%2C%20H.%2C%20Teshima%2C%20A.%2C%20Miura%2C%20F.%2C%20%26amp%3B%20Endo%2C%20A.%20%282024%29.%20%3Ci%3EProjecting%20international%20mpox%20spread%20in%20Asia%3A%20ongoing%20global%20health%20risk%3C%5C%2Fi%3E.%20medRxiv.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.04.17.24305832%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.04.17.24305832%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DEXMPAVZI%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Projecting%20international%20mpox%20spread%20in%20Asia%3A%20ongoing%20global%20health%20risk%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toshiaki%20R.%22%2C%22lastName%22%3A%22Asakura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sung-mok%22%2C%22lastName%22%3A%22Jung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroaki%22%2C%22lastName%22%3A%22Murayama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyrus%22%2C%22lastName%22%3A%22Ghaznavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haruka%22%2C%22lastName%22%3A%22Sakamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayaka%22%2C%22lastName%22%3A%22Teshima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fuminari%22%2C%22lastName%22%3A%22Miura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akira%22%2C%22lastName%22%3A%22Endo%22%7D%5D%2C%22abstractNote%22%3A%22The%20global%20mpox%20outbreak%20affected%20many%20Asian%20countries%20in%202023%2C%20following%20a%20sustained%20local%20transmission%20in%20Japan.%20Given%20the%20large%20population%20sizes%20and%20limited%20vaccine%20rollout%20in%20Asia%2C%20the%20potential%20risk%20of%20global%20mpox%20reemergence%20arising%20from%20Asia%20is%20of%20concern.%20Using%20a%20mathematical%20model%20incorporating%20heterogeneous%20sexual%20networks%20among%20MSM%2C%20calibrated%20to%20incidence%20data%20in%20Japan%2C%20we%20projected%20the%20patterns%20of%20international%20mpox%20spread%20across%2042%20Asian%20countries.%20Our%20simulations%20highlight%20countries%20at%20a%20high%20risk%20of%20mpox%20introductions%2C%20many%20of%20which%20were%20low-%20and%20middle-income%20countries%20%28LMICs%29%20in%20South-eastern%20Asia.%20Our%20analysis%20also%20suggests%20a%20shifting%20focus%20of%20importation%20risk%20from%20Eastern%20Asia%20to%20South-eastern%20Asia%2C%20and%20subsequently%20to%20Central%2C%20Southern%20and%20Western%20Asia%2C%20which%20roughly%20coincided%20with%20the%20observed%20spread%20patterns%20in%202023.%20Global%20cooperation%20and%20support%20are%20warranted%2C%20especially%20for%20LMICs%20with%20an%20elevated%20risk%20of%20mpox%20introduction%2C%20to%20minimise%20the%20risk%20of%20continued%20circulation%20in%20Asia%20and%20beyond.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22medRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-04-19%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.04.17.24305832%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.medrxiv.org%5C%2Fcontent%5C%2F10.1101%5C%2F2024.04.17.24305832v1%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-06-17T05%3A46%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22S4DZ2YQP%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rimal%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERimal%2C%20S.%2C%20Shrestha%2C%20S.%2C%20Paudel%2C%20S.%20W.%2C%20Shah%2C%20Y.%2C%20Bhandari%2C%20G.%2C%20Pandey%2C%20K.%2C%20Kharbuja%2C%20A.%2C%20Kapandji%2C%20M.%2C%20Gautam%2C%20I.%2C%20Bhujel%2C%20R.%2C%20Takamatsu%2C%20Y.%2C%20Bhandari%2C%20R.%2C%20Klungthong%2C%20C.%2C%20Shrestha%2C%20S.%20K.%2C%20Fernandez%2C%20S.%2C%20Malavige%2C%20G.%20N.%2C%20Pandey%2C%20B.%20D.%2C%20Urano%2C%20T.%2C%20Morita%2C%20K.%2C%20%26%23x2026%3B%20Dumre%2C%20S.%20P.%20%282024%29.%20Molecular%20and%20Entomological%20Characterization%20of%202023%20Dengue%20Outbreak%20in%20Dhading%20District%2C%20Central%20Nepal.%20%3Ci%3EViruses%3C%5C%2Fi%3E%2C%20%3Ci%3E16%3C%5C%2Fi%3E%284%29%2C%20594.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv16040594%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv16040594%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DS4DZ2YQP%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20and%20Entomological%20Characterization%20of%202023%20Dengue%20Outbreak%20in%20Dhading%20District%2C%20Central%20Nepal%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandesh%22%2C%22lastName%22%3A%22Rimal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabin%22%2C%22lastName%22%3A%22Shrestha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunita%20Wagle%22%2C%22lastName%22%3A%22Paudel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yogendra%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Govinda%22%2C%22lastName%22%3A%22Bhandari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kishor%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjana%22%2C%22lastName%22%3A%22Kharbuja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merveille%22%2C%22lastName%22%3A%22Kapandji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ishan%22%2C%22lastName%22%3A%22Gautam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajshree%22%2C%22lastName%22%3A%22Bhujel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rudramani%22%2C%22lastName%22%3A%22Bhandari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chonticha%22%2C%22lastName%22%3A%22Klungthong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjaya%20Kumar%22%2C%22lastName%22%3A%22Shrestha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Fernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gathsaurie%20Neelika%22%2C%22lastName%22%3A%22Malavige%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basu%20Dev%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%20Prakash%22%2C%22lastName%22%3A%22Dumre%22%7D%5D%2C%22abstractNote%22%3A%22In%202023%2C%20Nepal%20faced%20its%20second%20largest%20dengue%20outbreak%20ever%2C%20following%20a%20record-breaking%20number%20of%20dengue%20cases%20in%202022%2C%20characterized%20by%20the%20expansion%20of%20infections%20into%20areas%20of%20higher%20altitudes.%20However%2C%20the%20characteristics%20of%20the%202023%20circulating%20dengue%20virus%20%28DENV%29%20and%20the%20vector%20density%20remain%20poorly%20understood.%20Therefore%2C%20we%20performed%20DENV%20serotyping%2C%20clinical%20and%20laboratory%20assessment%2C%20and%20entomological%20analysis%20of%20the%202023%20outbreak%20in%20central%20Nepal.%20A%20total%20of%20396%20fever%20cases%20in%20Dhading%20hospital%20suspected%20of%20being%20DENV%20positive%20were%20enrolled%2C%20and%20blood%20samples%20were%20collected%20and%20tested%20by%20different%20techniques%20including%20PCR.%20Of%20these%2C%20278%20%2870.2%25%29%20had%20confirmed%20DENV%20infection.%20Multiple%20serotypes%20%28DENV-1%2C%20-2%2C%20and%20-3%29%20were%20detected.%20DENV-2%20%2897.5%25%29%20re-emerged%20after%20six%20years%20in%20Dhading%20while%20DENV-3%20was%20identified%20for%20the%20first%20time.%20Dengue%20inpatients%20had%20significantly%20higher%20frequency%20of%20anorexia%2C%20myalgia%2C%20rash%2C%20diarrhea%2C%20nausea%2C%20vomiting%2C%20abdominal%20pain%2C%20and%20thrombocytopenia%20%28p%20%3C%200.05%29.%20In%20this%20area%2C%20Aedes%20mosquitoes%20largely%20predominated%20%2890.7%25%29%20with%20the%20majority%20being%20A.%5Cu00a0aegypti%20%2860.7%25%29.%20We%20also%20found%20high%20levels%20of%20Aedes%20index%20%2820.0%25%29%20and%20container%20index%20%2816.7%25%29.%20We%20confirmed%20multiple%20DENV%20serotype%20circulation%20with%20serotype%20re-emergence%20and%20new%20serotype%20introduction%2C%20and%20high%20vector%20density%20in%202023.%20These%20findings%20call%20for%20the%20urgent%20initiation%20and%20scaling%20up%20of%20DENV%20molecular%20surveillance%20in%20human%20and%20mosquito%20populations%20for%20dengue%20control%20and%20prevention%20in%20Nepal.%22%2C%22date%22%3A%222024-04-12%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fv16040594%22%2C%22ISSN%22%3A%221999-4915%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1999-4915%5C%2F16%5C%2F4%5C%2F594%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-05-01T00%3A13%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22NVY85SH2%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hartner%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHartner%2C%20A.-M.%2C%20Li%2C%20X.%2C%20Echeverria-Londono%2C%20S.%2C%20Roth%2C%20J.%2C%20Abbas%2C%20K.%2C%20Auzenbergs%2C%20M.%2C%20De%20Villiers%2C%20M.%20J.%2C%20Ferrari%2C%20M.%20J.%2C%20Fraser%2C%20K.%2C%20Fu%2C%20H.%2C%20Hallett%2C%20T.%2C%20Hinsley%2C%20W.%2C%20Jit%2C%20M.%2C%20Karachaliou%2C%20A.%2C%20Moore%2C%20S.%20M.%2C%20Nayagam%2C%20S.%2C%20Papadopoulos%2C%20T.%2C%20Perkins%2C%20T.%20A.%2C%20Portnoy%2C%20A.%2C%20%26%23x2026%3B%20Gaythorpe%2C%20K.%20A.%20M.%20%282024%29.%20Estimating%20the%20health%20effects%20of%20COVID-19-related%20immunisation%20disruptions%20in%20112%20countries%20during%202020%26%23x2013%3B30%3A%20a%20modelling%20study.%20%3Ci%3EThe%20Lancet%20Global%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E12%3C%5C%2Fi%3E%284%29%2C%20e563%26%23x2013%3Be571.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2214-109X%2823%2900603-4%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2214-109X%2823%2900603-4%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DNVY85SH2%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimating%20the%20health%20effects%20of%20COVID-19-related%20immunisation%20disruptions%20in%20112%20countries%20during%202020%5Cu201330%3A%20a%20modelling%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna-Maria%22%2C%22lastName%22%3A%22Hartner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susy%22%2C%22lastName%22%3A%22Echeverria-Londono%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Roth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Auzenbergs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%20J%22%2C%22lastName%22%3A%22De%20Villiers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J%22%2C%22lastName%22%3A%22Ferrari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Han%22%2C%22lastName%22%3A%22Fu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Hallett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wes%22%2C%22lastName%22%3A%22Hinsley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Jit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andromachi%22%2C%22lastName%22%3A%22Karachaliou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20M%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shevanthi%22%2C%22lastName%22%3A%22Nayagam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timos%22%2C%22lastName%22%3A%22Papadopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T%20Alex%22%2C%22lastName%22%3A%22Perkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%22%2C%22lastName%22%3A%22Portnoy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Quan%20Tran%22%2C%22lastName%22%3A%22Minh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%22%2C%22lastName%22%3A%22Vynnycky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20K%22%2C%22lastName%22%3A%22Winter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Holly%22%2C%22lastName%22%3A%22Burrows%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%20E%22%2C%22lastName%22%3A%22Clapham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniruddha%22%2C%22lastName%22%3A%22Deshpande%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Hauryski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Huber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Jean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chaelin%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong-Hoon%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jemima%22%2C%22lastName%22%3A%22Koh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20A%22%2C%22lastName%22%3A%22Lopman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virginia%20E%22%2C%22lastName%22%3A%22Pitzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%22%2C%22lastName%22%3A%22Tam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%22%2C%22lastName%22%3A%22Lambach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22So%20Yoon%22%2C%22lastName%22%3A%22Sim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Woodruff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20M%22%2C%22lastName%22%3A%22Ferguson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20L%22%2C%22lastName%22%3A%22Trotter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katy%20A%20M%22%2C%22lastName%22%3A%22Gaythorpe%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2204%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2FS2214-109X%2823%2900603-4%22%2C%22ISSN%22%3A%222214109X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2214109X23006034%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-04-11T08%3A07%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22HGFVWXQF%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kang%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKang%2C%20H.%2C%20Auzenbergs%2C%20M.%2C%20Clapham%2C%20H.%2C%20Maure%2C%20C.%2C%20Kim%2C%20J.-H.%2C%20Salje%2C%20H.%2C%20Taylor%2C%20C.%20G.%2C%20Lim%2C%20A.%2C%20Clark%2C%20A.%2C%20Edmunds%2C%20W.%20J.%2C%20Sahastrabuddhe%2C%20S.%2C%20Brady%2C%20O.%20J.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20Chikungunya%20seroprevalence%2C%20force%20of%20infection%2C%20and%20prevalence%20of%20chronic%20disability%20after%20infection%20in%20endemic%20and%20epidemic%20settings%3A%20a%20systematic%20review%2C%20meta-analysis%2C%20and%20modelling%20study.%20%3Ci%3EThe%20Lancet%20Infectious%20Diseases%3C%5C%2Fi%3E%2C%20S1473309923008101.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2823%2900810-1%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2823%2900810-1%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DHGFVWXQF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chikungunya%20seroprevalence%2C%20force%20of%20infection%2C%20and%20prevalence%20of%20chronic%20disability%20after%20infection%20in%20endemic%20and%20epidemic%20settings%3A%20a%20systematic%20review%2C%20meta-analysis%2C%20and%20modelling%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hyolim%22%2C%22lastName%22%3A%22Kang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Auzenbergs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%22%2C%22lastName%22%3A%22Clapham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Maure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong-Hoon%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henrik%22%2C%22lastName%22%3A%22Salje%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20G%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahyoung%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W%20John%22%2C%22lastName%22%3A%22Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushant%22%2C%22lastName%22%3A%22Sahastrabuddhe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%20J%22%2C%22lastName%22%3A%22Brady%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2823%2900810-1%22%2C%22ISSN%22%3A%2214733099%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1473309923008101%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-04-11T08%3A06%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22R3MMW2RB%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Auzenbergs%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAuzenbergs%2C%20M.%2C%20Maure%2C%20C.%2C%20Kang%2C%20H.%2C%20Clark%2C%20A.%2C%20Brady%2C%20O.%2C%20Sahastrabuddhe%2C%20S.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20Programmatic%20considerations%20and%20evidence%20gaps%20for%20chikungunya%20vaccine%20introduction%20in%20countries%20at%20risk%20of%20chikungunya%20outbreaks%3A%20Stakeholder%20analysis.%20%3Ci%3EPLOS%20Neglected%20Tropical%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E18%3C%5C%2Fi%3E%284%29%2C%20e0012075.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0012075%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0012075%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DR3MMW2RB%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Programmatic%20considerations%20and%20evidence%20gaps%20for%20chikungunya%20vaccine%20introduction%20in%20countries%20at%20risk%20of%20chikungunya%20outbreaks%3A%20Stakeholder%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Auzenbergs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Maure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hyolim%22%2C%22lastName%22%3A%22Kang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Brady%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushant%22%2C%22lastName%22%3A%22Sahastrabuddhe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Adly%20M.%20M.%22%2C%22lastName%22%3A%22Abd-Alla%22%7D%5D%2C%22abstractNote%22%3A%22Chikungunya%20can%20have%20longstanding%20effects%20on%20health%20and%20quality%20of%20life.%20Alongside%20the%20recent%20approval%20of%20the%20world%5Cu2019s%20first%20chikungunya%20vaccine%20by%20the%20US%20Food%20and%20Drug%20Administration%20in%20November%202023%20and%20with%20new%20chikungunya%20vaccines%20in%20the%20pipeline%2C%20it%20is%20important%20to%20understand%20the%20perspectives%20of%20stakeholders%20before%20vaccine%20rollout.%20Our%20study%20aim%20is%20to%20identify%20key%20programmatic%20considerations%20and%20gaps%20in%20Evidence-to-Recommendation%20criteria%20for%20chikungunya%20vaccine%20introduction.%20We%20used%20purposive%20and%20snowball%20sampling%20to%20identify%20global%2C%20national%2C%20and%20subnational%20stakeholders%20from%20outbreak%20prone%20areas%2C%20including%20Latin%20America%2C%20Asia%2C%20and%20Africa.%20Semi-structured%20in-depth%20interviews%20were%20conducted%20and%20analysed%20using%20qualitative%20descriptive%20methods.%20We%20found%20that%20perspectives%20varied%20between%20tiers%20of%20stakeholders%20and%20geographies.%20Unknown%20disease%20burden%2C%20diagnostics%2C%20non-specific%20disease%20surveillance%2C%20undefined%20target%20populations%20for%20vaccination%2C%20and%20low%20disease%20prioritisation%20were%20critical%20challenges%20identified%20by%20stakeholders%20that%20need%20to%20be%20addressed%20to%20facilitate%20rolling%20out%20a%20chikungunya%20vaccine.%20Future%20investments%20should%20address%20these%20challenges%20to%20generate%20useful%20evidence%20for%20decision-making%20on%20new%20chikungunya%20vaccine%20introduction.%22%2C%22date%22%3A%222024-4-4%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0012075%22%2C%22ISSN%22%3A%221935-2735%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdx.plos.org%5C%2F10.1371%5C%2Fjournal.pntd.0012075%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-04-11T08%3A05%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22AAQWLFZT%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Williams%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWilliams%2C%20S.%20V.%2C%20Akande%2C%20T.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20Systematic%20review%20of%20social%20determinants%20of%20childhood%20immunisation%20in%20low-%20and%20middle-income%20countries%20and%20equity%20impact%20analysis%20of%20childhood%20vaccination%20coverage%20in%20Nigeria.%20%3Ci%3EPLOS%20ONE%3C%5C%2Fi%3E%2C%20%3Ci%3E19%3C%5C%2Fi%3E%283%29%2C%20e0297326.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0297326%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0297326%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DAAQWLFZT%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Systematic%20review%20of%20social%20determinants%20of%20childhood%20immunisation%20in%20low-%20and%20middle-income%20countries%20and%20equity%20impact%20analysis%20of%20childhood%20vaccination%20coverage%20in%20Nigeria%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20V.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanimola%22%2C%22lastName%22%3A%22Akande%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Harapan%22%2C%22lastName%22%3A%22Harapan%22%7D%5D%2C%22abstractNote%22%3A%22Background%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Nigeria%20has%20a%20high%20proportion%20of%20the%20world%5Cu2019s%20underimmunised%20children.%20We%20estimated%20the%20inequities%20in%20childhood%20immunisation%20coverage%20associated%20with%20socioeconomic%2C%20geographic%2C%20maternal%2C%20child%2C%20and%20healthcare%20characteristics%20among%20children%20aged%2012%5Cu201323%20months%20in%20Nigeria%20using%20a%20social%20determinants%20of%20health%20perspective.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20conducted%20a%20systematic%20review%20to%20identify%20the%20social%20determinants%20of%20childhood%20immunisation%20associated%20with%20inequities%20in%20vaccination%20coverage%20among%20low-%20and%20middle-income%20countries.%20Using%20the%202018%20Nigeria%20Demographic%20and%20Health%20Survey%20%28DHS%29%2C%20we%20conducted%20multiple%20logistic%20regression%20to%20estimate%20the%20association%20between%20basic%20childhood%20vaccination%20coverage%20%281-dose%20BCG%2C%203-dose%20DTP-HepB-Hib%20%28diphtheria%2C%20tetanus%2C%20pertussis%2C%20hepatitis%20B%20and%20Haemophilus%20influenzae%20type%20B%29%2C%203-dose%20polio%2C%20and%201-dose%20measles%29%20and%20socioeconomic%2C%20geographic%2C%20maternal%2C%20child%2C%20and%20healthcare%20characteristics%20in%20Nigeria.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20From%20the%20systematic%20review%2C%20we%20identified%20the%20key%20determinants%20of%20immunisation%20to%20be%20household%20wealth%2C%20religion%2C%20and%20ethnicity%20for%20socioeconomic%20characteristics%3B%20region%20and%20place%20of%20residence%20for%20geographic%20characteristics%3B%20maternal%20age%20at%20birth%2C%20maternal%20education%2C%20and%20household%20head%20status%20for%20maternal%20characteristics%3B%20sex%20of%20child%20and%20birth%20order%20for%20child%20characteristics%3B%20and%20antenatal%20care%20and%20birth%20setting%20for%20healthcare%20characteristics.%20Based%20of%20the%202018%20Nigeria%20DHS%20analysis%20of%206%2C059%20children%20aged%2012%5Cu201323%20months%2C%20we%20estimated%20that%20basic%20vaccination%20coverage%20was%2031%25%20%2895%25%20CI%3A%2029%5Cu201333%29%20among%20children%20aged%2012%5Cu201323%20months%2C%20whilst%2019%25%20%2895%25%20CI%3A18%5Cu201321%29%20of%20them%20were%20zero-dose%20children%20who%20had%20received%20none%20of%20the%20basic%20vaccines.%20After%20controlling%20for%20background%20characteristics%2C%20there%20was%20a%20significant%20increase%20in%20the%20odds%20of%20basic%20vaccination%20by%20household%20wealth%20%28AOR%3A%203.21%20%282.06%2C%205.00%29%2C%20p%20%3C%200.001%29%20for%20the%20wealthiest%20quintile%20compared%20to%20the%20poorest%20quintile%2C%20antenatal%20care%20of%20four%20or%20more%20antenatal%20care%20visits%20compared%20to%20no%20antenatal%20care%20%28AOR%3A%202.87%20%282.21%2C%203.72%29%2C%20p%20%3C%200.001%29%2C%20delivery%20in%20a%20health%20facility%20compared%20to%20home%20births%20%28AOR%201.32%20%281.08%2C%201.61%29%2C%20p%20%3D%200.006%29%2C%20relatively%20older%20maternal%20age%20of%2035%5Cu201349%20years%20compared%20to%2015%5Cu201319%20years%20%28AOR%3A%202.25%20%281.46%2C%203.49%29%2C%20p%20%3C%200.001%29%2C%20and%20maternal%20education%20of%20secondary%20or%20higher%20education%20compared%20to%20no%20formal%20education%20%28AOR%3A%201.79%20%281.39%2C%202.31%29%2C%20p%20%3C%200.001%29.%20Children%20of%20Fulani%20ethnicity%20in%20comparison%20to%20children%20of%20Igbo%20ethnicity%20had%20lower%20odds%20of%20receiving%20basic%20vaccinations%20%28AOR%3A%200.51%20%280.26%2C%200.97%29%2C%20p%20%3D%200.039%29.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusions%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Basic%20vaccination%20coverage%20is%20below%20target%20levels%20for%20all%20groups.%20Children%20from%20the%20poorest%20households%2C%20of%20Fulani%20ethnicity%2C%20who%20were%20born%20in%20home%20settings%2C%20and%20with%20young%20mothers%20with%20no%20formal%20education%20nor%20antenatal%20care%2C%20were%20associated%20with%20lower%20odds%20of%20basic%20vaccination%20in%20Nigeria.%20We%20recommend%20a%20proportionate%20universalism%20approach%20for%20addressing%20the%20immunisation%20barriers%20in%20the%20National%20Programme%20on%20Immunization%20of%20Nigeria.%22%2C%22date%22%3A%222024-3-6%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0297326%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdx.plos.org%5C%2F10.1371%5C%2Fjournal.pone.0297326%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-04-01T01%3A48%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22L7AGPE8C%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Abbas%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAbbas%2C%20K.%2C%20Yoo%2C%20K.%20J.%2C%20Prem%2C%20K.%2C%20%26amp%3B%20Jit%2C%20M.%20%282024%29.%20Equity%20impact%20of%20HPV%20vaccination%20on%20lifetime%20projections%20of%20cervical%20cancer%20burden%20among%20cohorts%20in%2084%20countries%20by%20global%2C%20regional%2C%20and%20income%20levels%2C%202010%26%23x2013%3B22%3A%20a%20modelling%20study.%20%3Ci%3EEClinicalMedicine%3C%5C%2Fi%3E%2C%20102524.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.eclinm.2024.102524%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.eclinm.2024.102524%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DL7AGPE8C%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Equity%20impact%20of%20HPV%20vaccination%20on%20lifetime%20projections%20of%20cervical%20cancer%20burden%20among%20cohorts%20in%2084%20countries%20by%20global%2C%20regional%2C%20and%20income%20levels%2C%202010%5Cu201322%3A%20a%20modelling%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katelyn%20Jison%22%2C%22lastName%22%3A%22Yoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiesha%22%2C%22lastName%22%3A%22Prem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Jit%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%223%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.eclinm.2024.102524%22%2C%22ISSN%22%3A%2225895370%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2589537024001032%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-04-01T01%3A43%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22UQAS2CIM%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222023-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Kyaw%2C%20A.%20K.%2C%20Nwe%2C%20K.%20M.%2C%20Myaing%2C%20S.%20S.%2C%20Win%2C%20Y.%20T.%2C%20Inoue%2C%20S.%2C%20Takamatsu%2C%20Y.%2C%20Urano%2C%20T.%2C%20Thu%2C%20H.%20M.%2C%20Hmone%2C%20S.%20W.%2C%20Thant%2C%20K.%20Z.%2C%20%26amp%3B%20Morita%2C%20K.%20%282023%29.%20Burden%20of%20Chikungunya%20Virus%20Infection%20during%20an%20Outbreak%20in%20Myanmar.%20%3Ci%3EViruses%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%288%29%2C%201734.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv15081734%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv15081734%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DUQAS2CIM%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Burden%20of%20Chikungunya%20Virus%20Infection%20during%20an%20Outbreak%20in%20Myanmar%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aung%20Kyaw%22%2C%22lastName%22%3A%22Kyaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khine%20Mya%22%2C%22lastName%22%3A%22Nwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%20Su%22%2C%22lastName%22%3A%22Myaing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ye%20Thu%22%2C%22lastName%22%3A%22Win%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hlaing%20Myat%22%2C%22lastName%22%3A%22Thu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saw%20Wutt%22%2C%22lastName%22%3A%22Hmone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyaw%20Zin%22%2C%22lastName%22%3A%22Thant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Chikungunya%20virus%20%28CHIKV%29%20infection%20is%20a%20re-emerging%20arboviral%20disease%20with%20no%20approved%20vaccine%2C%20although%20numerous%20options%20are%20in%20development.%20Before%20vaccine%20implementation%2C%20disease%20burden%2C%20affected%20age%20group%2C%20and%20hospitalization%20rate%20information%20should%20be%20documented.%20In%202019%2C%20a%20sizeable%20outbreak%20of%20the%20East%20Central%20South%20African%20genotype%20of%20CHIKV%20occurred%20in%20Myanmar%2C%20and%20during%20this%20period%2C%20a%20cross-sectional%20study%20was%20conducted%20in%20two%20regions%2C%20Mandalay%20and%20Yangon%2C%20to%20examine%20the%20molecular%20and%20seropositivity%20rate%20of%20the%20CHIKV%20infection.%20The%20participants%20%281124%29%20included%20dengue-suspected%20pediatric%20patients%2C%20blood%20donors%2C%20and%20healthy%20volunteers%2C%20who%20were%20assessed%20using%20molecular%20assays%20%28quantitative%20real-time%20RT-PCR%29%2C%20serological%20tests%20%28anti-CHIKV%20IgM%20capture%20and%20IgG%20indirect%20enzyme-linked%20immunosorbent%20assays%29%2C%20and%20neutralization%20tests.%20The%20tests%20confirmed%20the%20following%20positivity%20rates%3A%2011.3%25%20%28127%5C%2F1124%29%20for%20the%20molecular%20assay%2C%2012.4%25%20%28139%5C%2F1124%29%20for%20the%20anti-CHIKV%20IgM%20Ab%2C%2044.5%25%20%28500%5C%2F1124%29%20for%20the%20anti-CHIKV%20IgG%20Ab%2C%20and%2046.3%25%20%28520%5C%2F1124%29%20for%20the%20CHIKV%20neutralizing%20Ab.%20The%20highest%20rate%20for%20the%20molecular%20test%20occurred%20with%20the%20dengue-suspected%20pediatric%20patients.%20The%20seroprevalence%20rate%20through%20natural%20infection%20was%20higher%20in%20the%20healthy%20volunteers%20and%20blood%20donors%20than%20that%20in%20the%20pediatric%20patients.%20The%20results%20of%20this%20study%20will%20help%20stakeholders%20determine%20the%20criteria%20for%20choosing%20appropriate%20recipients%20when%20a%20CHIKV%20vaccine%20is%20introduced%20in%20Myanmar.%22%2C%22date%22%3A%222023%5C%2F8%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fv15081734%22%2C%22ISSN%22%3A%221999-4915%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1999-4915%5C%2F15%5C%2F8%5C%2F1734%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-05T02%3A53%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22NAN2WXZF%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Balingit%20et%20al.%22%2C%22parsedDate%22%3A%222024-02-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBalingit%2C%20J.%20C.%2C%20Dimamay%2C%20M.%20P.%20S.%2C%20Suzuki%2C%20R.%2C%20Matsuda%2C%20M.%2C%20Xayavong%2C%20D.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20Matias%2C%20R.%20R.%2C%20Natividad%2C%20F.%20F.%2C%20Moi%2C%20M.%20L.%2C%20Takamatsu%2C%20Y.%2C%20Culleton%2C%20R.%2C%20Buerano%2C%20C.%20C.%2C%20%26amp%3B%20Morita%2C%20K.%20%282024%29.%20Role%20of%20pre-existing%20immunity%20in%20driving%20the%20dengue%20virus%20serotype%202%20genotype%20shift%20in%20the%20Philippines%3A%20A%20retrospective%20analysis%20of%20serological%20data.%20%3Ci%3EInternational%20Journal%20of%20Infectious%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E139%3C%5C%2Fi%3E%2C%2059%26%23x2013%3B68.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijid.2023.11.025%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijid.2023.11.025%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DNAN2WXZF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Role%20of%20pre-existing%20immunity%20in%20driving%20the%20dengue%20virus%20serotype%202%20genotype%20shift%20in%20the%20Philippines%3A%20A%20retrospective%20analysis%20of%20serological%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Claude%22%2C%22lastName%22%3A%22Balingit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20Pierre%20S.%22%2C%22lastName%22%3A%22Dimamay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryosuke%22%2C%22lastName%22%3A%22Suzuki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mami%22%2C%22lastName%22%3A%22Matsuda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalouny%22%2C%22lastName%22%3A%22Xayavong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20R.%22%2C%22lastName%22%3A%22Matias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filipinas%20F.%22%2C%22lastName%22%3A%22Natividad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meng%20Ling%22%2C%22lastName%22%3A%22Moi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Culleton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corazon%20C.%22%2C%22lastName%22%3A%22Buerano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Objective%5CnThe%20invasion%20of%20dengue%20virus%20%28DENV%29-2%20Cosmopolitan%20genotype%20into%20the%20Philippines%2C%20where%20the%20Asian%20II%20genotype%20previously%20circulated%20challenges%20the%20principle%20of%20dengue%20serotype-specific%20immunity.%20Assessment%20of%20antibodies%20in%20this%20population%20may%20provide%20a%20mechanistic%20basis%20for%20how%20new%20genotypes%20emerge%20in%20dengue-endemic%20areas.%5CnMethods%5CnWe%20evaluated%20the%20neutralizing%20antibody%20%28nAb%29%20and%20antibody-dependent%20enhancement%20%28ADE%29%20responses%20against%20the%20two%20genotypes%20using%20archived%20serum%20samples%20collected%20from%20333%20patients%20with%20confirmed%20dengue%20in%20Metro%20Manila%2C%20Philippines%2C%20before%2C%20during%2C%20and%20after%20the%20introduction%20of%20the%20Cosmopolitan%20genotype.%20We%20quantified%20nAb%20titers%20in%20baby%20hamster%20kidney%20%28BHK-21%29%20cells%20with%20or%20without%20the%20Fc%5Cu03b3%20receptor%20IIA%20%28Fc%5Cu03b3RIIA%29%20to%20detect%20the%20capacity%20of%20virus-antibody%20complexes%20to%20neutralize%20or%20enhance%20DENV.%5CnResults%5CnThe%20nAb%20potency%20of%20the%20archived%20serum%20samples%20against%20the%20two%20genotypes%20was%20greatly%20affected%20by%20the%20presence%20of%20Fc%5Cu03b3RIIA.%20We%20found%20significant%20differences%20in%20nAb%20titers%20between%20the%20two%20genotypes%20in%20BHK-21%20cells%20with%20Fc%5Cu03b3RIIA%20%28P%5Cu00a0%3C0.0001%29.%20The%20archived%20serum%20samples%20were%20incapable%20of%20fully%20neutralizing%20the%20Cosmopolitan%20genotype%2C%20but%20instead%20strongly%20promoted%20its%20ADE%20compared%20to%20the%20Asian%20II%20genotype%20%28P%5Cu00a0%3C0.0001%29.%5CnConclusion%5CnThese%20results%20reinforce%20the%20role%20of%20pre-existing%20immunity%20in%20driving%20genotype%20shifts.%20Our%20finding%20that%20specific%20genotypes%20exhibit%20differing%20susceptibilities%20to%20ADE%20by%20cross-reactive%20antibodies%20may%20have%20implications%20for%20dengue%20vaccine%20development.%22%2C%22date%22%3A%222024-02-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2023.11.025%22%2C%22ISSN%22%3A%221201-9712%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1201971223007865%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-05T02%3A53%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22E525XR6W%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paul%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPaul%2C%20K.%20M.%20M.%2C%20Simpson%2C%20S.%20V.%2C%20Nundu%2C%20S.%20S.%2C%20Arima%2C%20H.%2C%20%26amp%3B%20Yamamoto%2C%20T.%20%282024%29.%20Genetic%20diversity%20of%20glutamate-rich%20protein%20%28GLURP%29%20in%20Plasmodium%20falciparum%20isolates%20from%20school-age%20children%20in%20Kinshasa%2C%20DRC.%20%3Ci%3EParasitology%20International%3C%5C%2Fi%3E%2C%20%3Ci%3E100%3C%5C%2Fi%3E%2C%20102866.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.parint.2024.102866%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.parint.2024.102866%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DE525XR6W%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genetic%20diversity%20of%20glutamate-rich%20protein%20%28GLURP%29%20in%20Plasmodium%20falciparum%20isolates%20from%20school-age%20children%20in%20Kinshasa%2C%20DRC%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kambale%20Mathe%20Mowa%22%2C%22lastName%22%3A%22Paul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shirley%20V.%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabin%20S.%22%2C%22lastName%22%3A%22Nundu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroaki%22%2C%22lastName%22%3A%22Arima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taro%22%2C%22lastName%22%3A%22Yamamoto%22%7D%5D%2C%22abstractNote%22%3A%22Malaria%20infections%20in%20school-age%20children%20further%20make%20it%20difficult%20to%20control%20the%20disease%27s%20spread.%20Moreover%2C%20the%20genetic%20diversity%20of%20glutamate-rich%20protein%2C%20potentially%20a%20candidate%20for%20vaccine%20development%2C%20has%20not%20yet%20been%20investigated%20in%20the%20Democratic%20Republic%20of%20Congo.%20Therefore%2C%20we%20aimed%20to%20assess%20the%20genetic%20diversity%20of%20the%20immunodominant%20C-terminal%20repetitive%20region%20%28R2%29%20of%20Plasmodium%20falciparum%20glutamate-rich%20protein%20gene%20%28pfglurp%29%20among%20school-age%20children%20living%20in%20Kinshasa%2C%20DRC.%20We%20conducted%20nested%20PCR%20targeting%20R2%20of%20pfglurp%20and%20the%20amplicon%20were%20directly%20sequenced.%20We%20summarized%20the%20prevalence%20of%20mutations%20of%20bases%20and%20amino%20acids%20and%20indicated%20the%20amino%20acid%20repeat%20sequence%20in%20the%20R2%20region%20by%20the%20unit%20code.%20We%20then%20statistically%20analyzed%20whether%20there%20was%20a%20relationship%20between%20the%20number%20of%20mutations%20in%20the%20pfglurp%20gene%20and%20attributes.%20In%20221%20samples%2C%20haplotype%201%20was%20the%20most%20common%20%28n%5Cu00a0%3D%5Cu00a0137%2C%2061.99%25%29%2C%20with%20the%20same%20sequence%20as%20the%203D7%20strain.%20Regarding%20the%20number%20of%20base%20mutations%2C%20it%20was%20higher%20in%20urban%20areas%20than%20rural%20areas%20%28p%5Cu00a0%3D%5Cu00a00.0363%29.%20When%20genetic%20neutrality%20was%20tested%20using%20data%20from%20171%20samples%20of%20the%20single%20strain%2C%20Tajima%27s%20D%20was%20%5Cu22121.857%20%28p%5Cu00a0%3D%5Cu00a00.0059%29.%20In%20addition%2C%20FST%20as%20the%20genetic%20distance%20between%20all%20attributes%20was%20very%20small%20and%20no%20significant%20difference%20was%20observed.%20This%20study%20clarified%20the%20genetic%20mutation%20status%20and%20relevant%20patient%20attributes%20among%20School-age%20children%20in%20the%20DRC.%20We%20found%20that%20urban%20areas%20are%20more%20likely%20to%20harbour%20pfglurp%20mutations.%20Future%20research%20needs%20to%20clarify%20the%20reason%20and%20mechanism%20involved.%22%2C%22date%22%3A%222024-06-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.parint.2024.102866%22%2C%22ISSN%22%3A%221383-5769%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1383576924000175%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-03T23%3A35%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22PUJINUPP%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mogasale%20et%20al.%22%2C%22parsedDate%22%3A%222024-02-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMogasale%2C%20V.%2C%20Sinha%2C%20A.%2C%20John%2C%20J.%2C%20Farooqui%2C%20H.%2C%20Ray%2C%20A.%2C%20Chantler%2C%20T.%2C%20Mogasale%2C%20V.%2C%20Dhoubhadel%2C%20B.%20G.%2C%20Edmunds%2C%20W.%20J.%2C%20Clark%2C%20A.%20D.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20%3Ci%3EResearch%20Priorities%20to%20Support%20Typhoid%20Conjugate%20Vaccine%20Decision-Making%20in%20India%3A%20Evidence%20Assessment%20and%20Stakeholder%20Survey%3C%5C%2Fi%3E%20%28SSRN%20Scholarly%20Paper%20No.%204714399%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4714399%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4714399%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DPUJINUPP%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Research%20Priorities%20to%20Support%20Typhoid%20Conjugate%20Vaccine%20Decision-Making%20in%20India%3A%20Evidence%20Assessment%20and%20Stakeholder%20Survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijayalaxmi%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anish%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Habib%22%2C%22lastName%22%3A%22Farooqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arindam%22%2C%22lastName%22%3A%22Ray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracey%22%2C%22lastName%22%3A%22Chantler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vittal%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhim%20Gopal%22%2C%22lastName%22%3A%22Dhoubhadel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20John%22%2C%22lastName%22%3A%22Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20India%20is%20a%20typhoid%20fever%20high-burden%20country.%20In%202022%2C%20the%20National%20Technical%20Advisory%20Group%20on%20Immunisation%20recommended%20introducing%20typhoid%20conjugate%20vaccination%20%28TCV%29%20into%20the%20Universal%20Immunisation%20Programme.%20Our%20study%20aims%20to%20identify%20research%20priorities%20to%20support%20ongoing%20TCV%20decision-making%20in%20India.Methods%3A%20We%20identified%2045%20evidence%20factors%20for%20TCV%20decision-making%20in%20India%20by%20adapting%20WHO%5Cu2019s%20Evidence-to-Recommendation%20criteria.%20We%20assigned%20an%20evidence%20gap%20score%20for%20each%20evidence%20factor%20from%200%20%28low%29%20to%204%20%28high%29%20based%20on%20the%20availability%2C%20sufficiency%2C%20quality%2C%20breadth%2C%20and%20applicability%20of%20evidence%20identified%20in%20a%20literature%20review%20%28end%20date%2030th%20November%202023%29.%20We%20assigned%20each%20evidence%20factor%20an%20importance%20score%20based%20on%20the%20results%20of%20an%20online%20survey%20among%20national%20stakeholders%20%28n%3D22%2C%201st%20July-31st%20October%202023%29%2C%20where%20they%20ranked%20the%20importance%20of%20seven%20WHO%5Cu2019s%20Evidence-to-Recommendation%20criteria%20and%20several%20evidence%20factors%20within%20them.%20Mean%20stakeholder%20rankings%20were%20rescaled%20into%20importance%20scores%20from%200%20%28low%29%20to%204%20%28high%29.%20The%20evidence%20gap%20score%20was%20added%20to%20the%20importance%20score%2C%20and%20the%20overall%20scores%20were%20used%20to%20identify%20research%20priorities.Findings%3A%20The%20evidence%20factors%20with%20the%20highest%20priority%20scores%20were%20the%20public%20perception%20of%20typhoid%20fever%2C%20vaccine%20budget%20impact%2C%20vaccine%20availability%2C%20socio-economic%20impact%2C%20fiscal%20space%2C%20antimicrobial%20resistance%20tracking%2C%20typhoid%20mortality%2C%20public%20perception%20of%20vaccine%2C%20immunisation%20managers%5Cu2019%20acceptance%2C%20and%20vaccine%20schedule%20preferences%20among%20caregivers.Interpretation%3A%20We%20have%20identified%20several%20priorities%20for%20TCV%20research%20in%20India.%20These%20priorities%20will%20evolve%20as%20new%20research%20studies%20and%20questions%20emerge%20about%20the%20optimal%20scheduling%2C%20roll-out%20and%20implementation%20of%20TCV%20in%20India.Funding%3A%20Nagasaki%20University%20WISE%20Programme.Declaration%20of%20Interest%3A%20The%20authors%20declare%20no%20competing%20interests.Ethical%20Approval%3A%20The%20research%20protocol%20for%20key%20stakeholders%5Cu2019%20survey%20was%20approved%20by%20the%20London%20School%20of%20Hygiene%20%26%20Tropical%20Medicine%20%28LSHTM%29%20Research%20Ethics%20Committee%20%28Ref.%20No%2028600%29%20and%20Institutional%20Ethics%20Committee%2C%20Indian%20Institute%20of%20Public%20Health%20%28IIPH%29%2C%20Gandhinagar%20%28Ref%3A%20TRC-IEC%20no%3A%2004%5C%2F2023-24%29.%22%2C%22genre%22%3A%22SSRN%20Scholarly%20Paper%22%2C%22repository%22%3A%22%22%2C%22archiveID%22%3A%224714399%22%2C%22date%22%3A%222024-02-05%22%2C%22DOI%22%3A%2210.2139%5C%2Fssrn.4714399%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpapers.ssrn.com%5C%2Fabstract%3D4714399%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-03T23%3A34%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22EQ2H54DE%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parajulee%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EParajulee%2C%20P.%2C%20Lee%2C%20J.-S.%2C%20Abbas%2C%20K.%2C%20Cannon%2C%20J.%2C%20Excler%2C%20J.%20L.%2C%20Kim%2C%20J.%20H.%2C%20%26amp%3B%20Mogasale%2C%20V.%20%282024%29.%20State%20transitions%20across%20the%20Strep%20A%20disease%20spectrum%3A%20scoping%20review%20and%20evidence%20gaps.%20%3Ci%3EBMC%20Infectious%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E24%3C%5C%2Fi%3E%281%29%2C%20108.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12879-023-08888-4%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12879-023-08888-4%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DEQ2H54DE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22State%20transitions%20across%20the%20Strep%20A%20disease%20spectrum%3A%20scoping%20review%20and%20evidence%20gaps%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prerana%22%2C%22lastName%22%3A%22Parajulee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jung-Seok%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Cannon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Louis%22%2C%22lastName%22%3A%22Excler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%20H.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vittal%22%2C%22lastName%22%3A%22Mogasale%22%7D%5D%2C%22abstractNote%22%3A%22The%20spectrum%20of%20diseases%20caused%20by%20Streptococcus%20pyogenes%20%28Strep%20A%29%20ranges%20from%20superficial%20to%20serious%20life-threatening%20invasive%20infections.%20We%20conducted%20a%20scoping%20review%20of%20published%20articles%20between%201980%20and%202021%20to%20synthesize%20evidence%20of%20state%20transitions%20across%20the%20Strep%20A%20disease%20spectrum.%20We%20identified%20175%20articles%20reporting%20262%20distinct%20observations%20of%20Strep%20A%20disease%20state%20transitions.%20Among%20the%20included%20articles%2C%20the%20transition%20from%20an%20invasive%20or%20toxin-mediated%20disease%20state%20to%20another%20disease%20state%20%28i.e.%2C%20to%20recurrent%20ARF%2C%20RHD%20or%20death%29%20was%20described%20115%20times%20%2843.9%25%20of%20all%20included%20transition%20pairs%29%20while%20the%20transition%20to%20and%20from%20locally%20invasive%20category%20was%20the%20lowest%20%28n%5Cu2009%3D%5Cu20097%3B%200.02%25%29.%20Transitions%20from%20well%20to%20any%20other%20state%20was%20most%20frequently%20reported%20%2849%25%29%20whereas%20a%20relatively%20higher%20number%20of%20studies%20%28n%5Cu2009%3D%5Cu200971%29%20reported%20transition%20from%20invasive%20disease%20to%20death.%20Transitions%20from%20any%20disease%20state%20to%20locally%20invasive%2C%20Strep%20A%20pharyngitis%20to%20invasive%20disease%2C%20and%20chronic%20kidney%20disease%20to%20death%20were%20lacking.%20Transitions%20related%20to%20severe%20invasive%20diseases%20were%20more%20frequently%20reported%20than%20superficial%20ones.%20Most%20evidence%20originated%20from%20high-income%20countries%20and%20there%20is%20a%20critical%20need%20for%20new%20studies%20in%20low-%20and%20middle-income%20countries%20to%20infer%20the%20state%20transitions%20across%20the%20Strep%20A%20disease%20spectrum%20in%20these%20high-burden%20settings.%22%2C%22date%22%3A%222024-01-19%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12879-023-08888-4%22%2C%22ISSN%22%3A%221471-2334%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12879-023-08888-4%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-03T23%3A30%3A25Z%22%7D%7D%2C%7B%22key%22%3A%227BX78VTU%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Naylor%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-29%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENaylor%2C%20N.%20R.%2C%20Hasso-Agopsowicz%2C%20M.%2C%20Kim%2C%20C.%2C%20Ma%2C%20Y.%2C%20Frost%2C%20I.%2C%20Abbas%2C%20K.%2C%20Aguilar%2C%20G.%2C%20Fuller%2C%20N.%20M.%2C%20Robotham%2C%20J.%20V.%2C%20%26amp%3B%20Jit%2C%20M.%20%282023%29.%20%3Ci%3EThe%20Global%20Economic%20Burden%20of%20Antibiotic%20Resistant%20Infections%20and%20the%20Potential%20Impact%20of%20Bacterial%20Vaccines%3A%20A%20Modelling%20Study%3C%5C%2Fi%3E%20%28SSRN%20Scholarly%20Paper%20No.%204676946%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4676946%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4676946%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3D7BX78VTU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22The%20Global%20Economic%20Burden%20of%20Antibiotic%20Resistant%20Infections%20and%20the%20Potential%20Impact%20of%20Bacterial%20Vaccines%3A%20A%20Modelling%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nichola%20R.%22%2C%22lastName%22%3A%22Naylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateusz%22%2C%22lastName%22%3A%22Hasso-Agopsowicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chaelin%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yixuan%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Frost%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gisela%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20M.%22%2C%22lastName%22%3A%22Fuller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20V.%22%2C%22lastName%22%3A%22Robotham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Jit%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Antibiotic%20resistance%20%28ABR%29%20may%20increase%20hospital%20costs%2C%20utility%20loss%20and%20mortality%20risk%20per%20patient.%20Our%20aim%20is%20to%20estimate%20the%20global%20economic%20burden%20of%20antibiotic%20resistant%20infections%20and%20the%20potential%20for%20vaccines%20to%20mitigate%20this%20burden.Methods%3A%20We%20take%20healthcare%20system%20and%20labour%20productivity%20perspectives.%20Hospital%20cost-per-case%20and%20length-of-stay%20estimates%20were%20calculated%20through%20meta-analyses%20and%20reviewing%20published%20systematic%20reviews.%20Unit%20labour%20productivity%20losses%20were%20estimated%20through%20a%20human%20capital%20approach.%20Death%20and%20incidence%20data%20were%20combined%20with%20unit%20cost%20data%20to%20estimate%20the%20economic%20burden%20associated%20with%20ABR%20in%202019%2C%20and%20the%20potential%20costs%20averted%20%28in%202019%20USD%29%20based%20on%20uptake%20scenarios%20of%20vaccines%20that%20currently%20exist%20or%20are%20likely%20to%20be%20developed.%20Findings%3A%20%20Out%20of%20all%20the%20organisms%20studied%2C%20multi-drug%20resistant%20tuberculosis%20had%20the%20highest%20mean%20hospital%20cost%20attributable%20to%20ABR%20per%20patient%20of%20%243%2C000%20-%20%2441%2C000%20depending%20on%20region%20%2C%20with%20carbapenem-resistant%20infections%20associated%20with%20a%20high%20cost-per-case%20of%20%243%2C000%20-%20%247%2C000%20depending%20on%20syndrome.%20ABR%20was%20associated%20with%20a%20median%20value%20of%20%24693%20billion%20%28interquartile%20range%20%28IQR%29%3A%20%24627%20bn%20%5Cu2013%20%24768%20bn%29%20in%20hospital%20costs%20globally%2C%20with%20%24207%20bn%20%28IQR%3A%20%24186%20bn%20%5Cu2013%20%24229%20bn%29%20potentially%20avertable%20by%20vaccines.%20Productivity%20losses%20were%20quantified%20at%20almost%20%24194%20billion%2C%20with%20%2476%20bn%20avertable%20by%20vaccines.%5Cu00a0Interpretation%3A%20The%20global%20economic%20burden%20associated%20with%20ABR%20is%20substantial%2C%20with%20bacterial%20vaccines%20a%20priority%20investment%20in%20alleviating%20this%20burden.%20Vaccines%20against%20S.%20aureus%2C%20E.%20coli%20and%20K.%20pneumoniae%20would%20avert%20a%20substantial%20portion%20of%20economic%20burden%20associated%20with%20ABR.Funding%3A%20Bill%20%26%20Melinda%20Gates%20Foundation%20%28INV-005318%29%20funding%20was%20used%20for%20this%20study.%20KA%20was%20supported%20by%20the%20Japan%20Agency%20for%20Medical%20Research%20and%20Development%20%28JP223fa627004%29.%20JVR%20was%20supported%20by%20the%20National%20Institute%20for%20Health%20Research%20%28NIHR%29%20Health%20Protection%20Research%20Unit%20in%20Healthcare%20Associated%20Infections%20and%20Antimicrobial%20Resistance%20%28NIHR200915%29%2C%20a%20partnership%20between%20the%20UK%20Health%20Security%20Agency%20%28UKHSA%29%20and%20the%20University%20of%20Oxford.Declaration%20of%20Interest%3A%20IF%20now%20works%20for%20AstraZeneca%20but%20was%20working%20at%20the%20World%20Health%20Organisation%20when%20this%20study%20was%20conducted%2C%20with%20no%20competing%20interests%20to%20declare%20at%20that%20time.%20The%20other%20authors%20declare%20no%20competing%20interests.Ethical%20Approval%3A%20All%20data%20used%20in%20this%20study%20were%20publicly%20accessible.%20Any%20engagement%20with%20experts%20did%20not%20involve%20any%20personal%20information%20and%20the%20Ethical%20Committee%20of%20the%20World%20Health%20Organization%20agreed%20that%20the%20ethical%20approval%20was%20not%20required.%22%2C%22genre%22%3A%22SSRN%20Scholarly%20Paper%22%2C%22repository%22%3A%22%22%2C%22archiveID%22%3A%224676946%22%2C%22date%22%3A%222023-12-29%22%2C%22DOI%22%3A%2210.2139%5C%2Fssrn.4676946%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpapers.ssrn.com%5C%2Fabstract%3D4676946%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-03T23%3A29%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22PPCN663I%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Murayama%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMurayama%2C%20H.%2C%20Endo%2C%20A.%2C%20%26amp%3B%20Yonekura%2C%20S.%20%282023%29.%20Estimation%20of%20waning%20vaccine%20effectiveness%20from%20population-level%20surveillance%20data%20in%20multi-variant%20epidemics.%20%3Ci%3EEpidemics%3C%5C%2Fi%3E%2C%20%3Ci%3E45%3C%5C%2Fi%3E%2C%20100726.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.epidem.2023.100726%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.epidem.2023.100726%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DPPCN663I%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimation%20of%20waning%20vaccine%20effectiveness%20from%20population-level%20surveillance%20data%20in%20multi-variant%20epidemics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroaki%22%2C%22lastName%22%3A%22Murayama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akira%22%2C%22lastName%22%3A%22Endo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shouto%22%2C%22lastName%22%3A%22Yonekura%22%7D%5D%2C%22abstractNote%22%3A%22Monitoring%20time-varying%20vaccine%20effectiveness%20%28e.g.%2C%20due%20to%20waning%20of%20immunity%20and%20the%20emergence%20of%20novel%20variants%29%20provides%20crucial%20information%20for%20outbreak%20control.%20Existing%20studies%20of%20time-varying%20vaccine%20effectiveness%20have%20used%20individual-level%20data%2C%20most%20importantly%20dates%20of%20vaccination%20and%20variant%20classification%2C%20which%20are%20often%20not%20available%20in%20a%20timely%20manner%20or%20from%20a%20wide%20range%20of%20population%20groups.%20We%20present%20a%20novel%20Bayesian%20framework%20for%20estimating%20the%20waning%20of%20variant-specific%20vaccine%20effectiveness%20in%20the%20presence%20of%20multi-variant%20circulation%20from%20population-level%20surveillance%20data.%20Applications%20to%20simulated%20outbreaks%20and%20the%20COVID-19%20epidemic%20in%20Japan%20are%20also%20presented.%20Our%20results%20show%20that%20variant-specific%20waning%20vaccine%20effectiveness%20estimated%20from%20population-level%20surveillance%20data%20could%20approximately%20reproduce%20the%20estimates%20from%20previous%20test-negative%20design%20studies%2C%20allowing%20for%20rapid%2C%20if%20crude%2C%20assessment%20of%20the%20epidemic%20situation%20before%20fine-scale%20studies%20are%20made%20available.%22%2C%22date%22%3A%222023-12-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.epidem.2023.100726%22%2C%22ISSN%22%3A%221755-4365%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1755436523000622%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-03T23%3A26%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22IMZGBBAD%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222023-09-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Raini%2C%20S.%20K.%2C%20Fernando%2C%20L.%2C%20Gunawardene%2C%20Y.%2C%20Inoue%2C%20S.%2C%20Takamatsu%2C%20Y.%2C%20Urano%2C%20T.%2C%20Muthugala%2C%20R.%2C%20Hapugoda%2C%20M.%2C%20%26amp%3B%20Morita%2C%20K.%20%282023%29.%20Epidemiological%20evidence%20of%20acute%20transmission%20of%20Zika%20virus%20infection%20in%20dengue%20suspected%20patients%20in%20Sri-Lanka.%20%3Ci%3EJournal%20of%20Infection%20and%20Public%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E16%3C%5C%2Fi%3E%289%29%2C%201435%26%23x2013%3B1442.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2023.07.014%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2023.07.014%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DIMZGBBAD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Epidemiological%20evidence%20of%20acute%20transmission%20of%20Zika%20virus%20infection%20in%20dengue%20suspected%20patients%20in%20Sri-Lanka%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Kendra%22%2C%22lastName%22%3A%22Raini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lakkumar%22%2C%22lastName%22%3A%22Fernando%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22YINS%22%2C%22lastName%22%3A%22Gunawardene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohitha%22%2C%22lastName%22%3A%22Muthugala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Menaka%22%2C%22lastName%22%3A%22Hapugoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnZika%20Virus%20%28ZIKV%29%20is%20a%20re-emerging%2C%20arthropod-borne%20flavivirus%20transmitted%20by%20Aedes%20mosquitoes%20%28Ae.%20aegypti%20and%20Ae.%20albopictus%29.%20The%20coexistence%20of%20dengue%20virus%20%28DENV%29%20and%20ZIKV%20concurrently%20has%20been%20associated%20with%20a%20wide%20array%20of%20neurological%20complications%2C%20which%20may%20influence%20the%20clinical%20outcomes%20of%20infections.%20Sri%20Lanka%20witnessed%20a%20severe%20dengue%20epidemic%20in%202017%2C%20characterized%20by%20extraordinary%20and%20severe%20disease%20manifestations%20with%20considerable%20morbidity.%20Therefore%2C%20this%20study%20assessed%20the%20potential%20occurrence%20of%20ZIKV%20infection%20during%20DENV%20outbreak%20in%20Sri%20Lanka%20from%202017%20to%202019%2C%20which%20could%20bear%20substantial%20implications%20for%20public%20health.%5CnMethods%5CnFive%20hundred%20ninety-five%20serum%20samples%20were%20procured%20from%20individuals%20suspected%20of%20dengue%20and%20admitted%20to%20Kandy%20National%20Hospital%20between%202017%20and%202018%20and%20the%20Negombo%20District%20General%20Hospital%20between%202018%20and%202019.%20These%20samples%20underwent%20quantitative%20real-time%20RT-PCR%20%28qRT-PCR%29%20to%20identify%20the%20presence%20of%20the%20ZIKV%20gene%2C%20while%20enzyme-linked%20immunosorbent%20assay%20was%20employed%20to%20detect%20ZIKV-specific%20IgM%20and%20IgG%20antibodies.%20Focus%20reduction%20neutralization%20tests%20were%20subsequently%20conducted%20to%20confirm%20ZIKV%20infection.%5CnResults%5CnAmong%20the%20595%20serum%20samples%2C%206%20%281.0%25%29%20tested%20positive%20for%20ZIKV%20using%20qRT-PCR.%20Anti-ZIKV%20IgM%20and%20IgG%20were%20identified%20in%2018.0%25%20and%2038.6%25%20patients.%20Sixty-six%20%2811.0%25%29%20samples%20demonstrated%20the%20presence%20of%20anti-ZIKV%20IgM%20and%20IgG.%20Within%20ZIKV%20IgM-positive%20samples%2C%202.2%25%20exhibited%20neutralizing%20antibodies%20against%20ZIKV.%20Through%20the%20implementation%20of%20qRT-PCR%2C%20ZIKV%20IgM%20detection%2C%20and%20neutralization%20testing%2C%202%25%20and%203.7%25%20cases%20of%20ZIKV%20infections%20were%20confirmed%20in%20the%20Kandy%20and%20Negombo%20regions%2C%20respectively.%5CnConclusion%5CnThis%20study%20is%20the%20inaugural%20endeavor%20to%20substantiate%20the%20existence%20of%20ZIKV%20infection%20in%20Sri%20Lanka%20utilizing%20molecular%20and%20serological%20analysis.%20The%20findings%20of%20this%20investigation%20imply%20that%20ZIKV%20was%20circulating%20throughout%20the%202017%5Cu20132019%20DENV%20outbreak.%20These%20results%20underscore%20the%20necessity%20for%20improved%20preparedness%20for%20future%20outbreaks%2C%20fortifying%20governmental%20policies%20on%20public%20health%2C%20and%20establishing%20effective%20early%20warning%20systems%20regarding%20the%20emergence%20of%20these%20viruses.%22%2C%22date%22%3A%222023-09-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jiph.2023.07.014%22%2C%22ISSN%22%3A%221876-0341%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1876034123002484%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-01-26T08%3A32%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22EKJPG48W%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nwe%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENwe%2C%20K.%20M.%2C%20Tun%2C%20M.%20M.%20N.%2C%20Muthugala%2C%20R.%2C%20Nabeshima%2C%20T.%2C%20Balingit%2C%20J.%20C.%2C%20Rajamanthri%2C%20L.%2C%20Jayawardana%2C%20D.%2C%20Attanayake%2C%20S.%2C%20Inoue%2C%20S.%2C%20Takamatsu%2C%20Y.%2C%20Urano%2C%20T.%2C%20%26amp%3B%20Morita%2C%20K.%20%282023%29.%20Clinical%2C%20Virological%2C%20and%20Immunological%20Features%20in%20Cosmopolitan%20Genotype%20DENV-2%26%23x2013%3BInfected%20Patients%20during%20a%20Large%20Dengue%20Outbreak%20in%20Sri%20Lanka%20in%202017.%20%3Ci%3EThe%20American%20Journal%20of%20Tropical%20Medicine%20and%20Hygiene%3C%5C%2Fi%3E%2C%20%3Ci%3E109%3C%5C%2Fi%3E%284%29%2C%20917%26%23x2013%3B925.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4269%5C%2Fajtmh.22-0780%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4269%5C%2Fajtmh.22-0780%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DEKJPG48W%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%2C%20Virological%2C%20and%20Immunological%20Features%20in%20Cosmopolitan%20Genotype%20DENV-2%5Cu2013Infected%20Patients%20during%20a%20Large%20Dengue%20Outbreak%20in%20Sri%20Lanka%20in%202017%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khine%20Mya%22%2C%22lastName%22%3A%22Nwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%20Ngwe%22%2C%22lastName%22%3A%22Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohitha%22%2C%22lastName%22%3A%22Muthugala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Nabeshima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Claude%22%2C%22lastName%22%3A%22Balingit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lakmali%22%2C%22lastName%22%3A%22Rajamanthri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dulani%22%2C%22lastName%22%3A%22Jayawardana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shanthi%22%2C%22lastName%22%3A%22Attanayake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT.%20In%202017%2C%20Sri%20Lanka%20experienced%20its%20largest%20dengue%20epidemic%20and%20reported%20severe%20and%20unusual%20presentations%20of%20dengue%20with%20high%20morbidity.%20This%20outbreak%20was%20associated%20with%20the%20reemergence%20of%20dengue%20virus-2%20%28DENV-2%29%2C%20with%20the%20responsible%20strain%20identified%20as%20a%20variant%20of%20the%20previously%20circulating%20DENV-2%20cosmopolitan%20genotype.%20In%20this%20study%2C%20we%20characterized%20the%20DENV-2%20cosmopolitan%20genotype%20from%20patients%20during%20this%20epidemic.%20Also%2C%20we%20identified%20host%20factors%20that%20contributed%20to%20the%20severity%20of%20dengue%20infection%20in%20patients%20infected%20with%20this%20particular%20virus.%20Ninety-one%20acute%20serum%20samples%20from%20patients%20at%20the%20National%20Hospital%20in%20Kandy%20were%20randomly%20selected.%20Of%20these%2C%2040.2%25%20and%2048.9%25%20were%20positive%20for%20dengue%20IgM%20and%20IgG%2C%20respectively.%20NS1%20antigen%20levels%20were%20significantly%20higher%20in%20primary%20infections.%20The%20severe%20dengue%20%28SD%29%20and%20dengue%20with%20warning%20signs%20%28DWWS%29%20groups%20exhibited%20significantly%20higher%20viral%20genome%20and%20infectivity%20titers%20than%20the%20dengue%20without%20warning%20signs%20%28DWoWS%29%20group.%20The%20highest%20viremia%20level%20was%20observed%20in%20SD%20patients.%20As%20for%20host%20cytokine%20response%2C%20interferon%20%5Cu03b1%20%28IFN-%5Cu03b1%29%20levels%20were%20significantly%20higher%20in%20the%20DWoWS%20group%20than%20in%20the%20DWWS%20and%20SD%20groups%2C%20whereas%20interleukin%20%28IL%29-12p40%20and%20tumor%20necrosis%20factor%20%5Cu03b1%20%28TNF-%5Cu03b1%29%20levels%20in%20SD%20patients%20were%20significantly%20higher%20than%20in%20the%20other%20two%20groups.%20The%20TNF-%5Cu03b1%2C%20IL-4%2C%20and%20monocyte%20chemoattractant%20protein-1%20concentrations%20were%20positively%20correlated%20with%20NS1%20antigen%20levels.%20From%20whole-genome%20analysis%2C%20NS4%20had%20the%20highest%20frequency%20of%20amino%20acid%20variants%2C%20followed%20by%20the%20E%20gene.%20Our%20study%20suggests%20that%20viremia%20levels%20and%20immune%20responses%20contributed%20to%20SD%20outcomes%2C%20and%20these%20findings%20may%20help%20in%20identifying%20an%20effective%20therapeutic%20strategy%20against%20SD%20infection.%22%2C%22date%22%3A%222023%5C%2F10%5C%2F04%22%2C%22language%22%3A%22EN%22%2C%22DOI%22%3A%2210.4269%5C%2Fajtmh.22-0780%22%2C%22ISSN%22%3A%220002-9637%2C%201476-1645%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ajtmh.org%5C%2Fview%5C%2Fjournals%5C%2Ftpmd%5C%2F109%5C%2F4%5C%2Farticle-p917.xml%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-01-26T08%3A30%3A30Z%22%7D%7D%2C%7B%22key%22%3A%22DH8DJWTZ%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Nwe%2C%20K.%20M.%2C%20Balingit%2C%20J.%20C.%2C%20Takamatsu%2C%20Y.%2C%20Inoue%2C%20S.%2C%20Pandey%2C%20B.%20D.%2C%20Urano%2C%20T.%2C%20Kohara%2C%20M.%2C%20Tsukiyama-Kohara%2C%20K.%2C%20%26amp%3B%20Morita%2C%20K.%20%282023%29.%20A%20Novel%2C%20Comprehensive%20A129%20Mouse%20Model%20for%20Investigating%20Dengue%20Vaccines%20and%20Evaluating%20Pathogenesis.%20%3Ci%3EVaccines%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%2812%29%2C%201857.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fvaccines11121857%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fvaccines11121857%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DDH8DJWTZ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Novel%2C%20Comprehensive%20A129%20Mouse%20Model%20for%20Investigating%20Dengue%20Vaccines%20and%20Evaluating%20Pathogenesis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khine%20Mya%22%2C%22lastName%22%3A%22Nwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Claude%22%2C%22lastName%22%3A%22Balingit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basu%20Dev%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michinori%22%2C%22lastName%22%3A%22Kohara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyoko%22%2C%22lastName%22%3A%22Tsukiyama-Kohara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22In%20search%20of%20a%20mouse%20model%20for%20use%20in%20evaluating%20dengue%20vaccines%2C%20we%20assessed%20A129%20mice%20that%20lacked%20IFN-%5Cu03b1%5C%2F%5Cu03b2%20receptors%2C%20rendering%20them%20susceptible%20to%20dengue%20virus%20%28DENV%29%20infection.%20To%20our%20knowledge%2C%20no%20reports%20have%20evaluated%20dengue%20vaccine%20efficiency%20using%20A129%20mice.%20A129%20mice%20were%20given%20a%20single%20intraperitoneal%20%28IP%29%20or%20subcutaneous%20%28SC%29%20injection%20of%20the%20vaccine%2C%20Dengvaxia.%20After%2014%20days%20of%20immunization%20via%20the%20IP%20or%20SC%20injection%20of%20Dengvaxia%2C%20the%20A129%20mice%20exhibited%20notably%20elevated%20levels%20of%20anti-DENV%20immunoglobulin%20G%20and%20neutralizing%20antibodies%20%28NAb%29%20targeting%20all%20four%20DENV%20serotypes%2C%20with%20DENV-4%20displaying%20the%20highest%20NAb%20levels.%20After%20challenge%20with%20DENV-2%2C%20Dengvaxia%20and%20mock-immunized%20mice%20survived%2C%20while%20only%20the%20mock%20group%20exhibited%20signs%20of%20morbidity.%20Viral%20genome%20levels%20in%20the%20serum%20and%20tissues%20%28excluding%20the%20brain%29%20were%20considerably%20lower%20in%20the%20immunized%20mice%20compared%20to%20those%20in%20the%20mock%20group.%20The%20SC%20administration%20of%20Dengvaxia%20resulted%20in%20lower%20viremia%20levels%20than%20IP%20administration%20did.%20Therefore%2C%20given%20that%20A129%20mice%20manifest%20dengue-related%20morbidity%2C%20including%20viremia%20in%20the%20serum%20and%20other%20tissues%2C%20these%20mice%20represent%20a%20valuable%20model%20for%20investigating%20novel%20dengue%20vaccines%20and%20antiviral%20drugs%20and%20for%20exploring%20dengue%20pathogenesis.%22%2C%22date%22%3A%222023-12-15%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3390%5C%2Fvaccines11121857%22%2C%22ISSN%22%3A%222076-393X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC10748371%5C%2F%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-01-26T08%3A29%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22CJAU27X4%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Furuse%22%2C%22parsedDate%22%3A%222024-01-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFuruse%2C%20Y.%20%282024%29.%20Characteristics%20of%20retracted%20research%20papers%20before%20and%20during%20the%20COVID-19%20pandemic.%20%3Ci%3EFrontiers%20in%20Medicine%3C%5C%2Fi%3E%2C%20%3Ci%3E10%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticles%5C%2F10.3389%5C%2Ffmed.2023.1288014%27%3Ehttps%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticles%5C%2F10.3389%5C%2Ffmed.2023.1288014%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DCJAU27X4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characteristics%20of%20retracted%20research%20papers%20before%20and%20during%20the%20COVID-19%20pandemic%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Furuse%22%7D%5D%2C%22abstractNote%22%3A%22ObjectivesDuring%20the%20COVID-19%20pandemic%2C%20a%20large%20number%20of%20research%20papers%20were%20published%2C%20and%20some%20of%20them%20were%20retracted.%20The%20present%20study%20aims%20to%20reveal%20the%20characteristics%20of%20retracted%20papers%20before%20and%20during%20the%20pandemic.MethodsThe%20study%20investigated%2024%2C542%2C394%20publications%20from%201999%20to%202022%20and%20analyzed%20the%20profiles%20of%20retracted%20papers%20from%20the%20perspectives%20of%20year%2C%20disease%20category%2C%20country%2C%20and%20journal.ResultsRetraction%20rates%20were%20generally%20increasing%20at%20least%20until%202019%2C%20and%20were%20the%20highest%20for%20%5Cu201cNeoplasms.%5Cu201d%20The%20number%20of%20publications%20for%20%5Cu201cInfections%5Cu201d%20and%20%5Cu201cRespiratory%20Tract%20Diseases%5Cu201d%20dramatically%20rose%20during%20the%20COVID-19%20pandemic%3B%20however%2C%20the%20retraction%20rates%20in%20the%20two%20categories%20or%20of%20COVID-19-related%20papers%20were%20not%20especially%20high%20compared%20to%20other%20diseases.%20The%20association%20with%20retraction%20was%20strongest%20for%20China%20in%20most%20disease%20categories%2C%20whereas%20for%20COVID-19%20papers%2C%20other%20countries%20showed%20higher%20retraction%20rates%20than%20China.%20In%20recent%20years%2C%20retracted%20papers%20have%20become%20less%20likely%20to%20be%20published%20in%20high-impact%20journals.ConclusionThe%20COVID-19%20pandemic%20does%20not%20seem%20to%20affect%20the%20retractions%20of%20research%20papers%20much.%20We%20should%20keep%20monitoring%20retractions%20and%20analyze%20the%20effects%20of%20pandemics%20for%20better%20science.%22%2C%22date%22%3A%222024-01-10%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%222296-858X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticles%5C%2F10.3389%5C%2Ffmed.2023.1288014%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-01-25T05%3A28%3A51Z%22%7D%7D%2C%7B%22key%22%3A%224URLGRL3%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yoshikawa%20et%20al.%22%2C%22parsedDate%22%3A%222023-05-13%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EYoshikawa%2C%20R.%2C%20Kawakami%2C%20M.%2C%20%26amp%3B%20Yasuda%2C%20J.%20%282023%29.%20The%20NSs%20protein%20of%20severe%20fever%20with%20thrombocytopenia%20syndrome%20virus%20differentially%20inhibits%20the%20type%201%20interferon%20response%20among%20animal%20species.%20%3Ci%3EJournal%20of%20Biological%20Chemistry%3C%5C%2Fi%3E%2C%20%3Ci%3E299%3C%5C%2Fi%3E%286%29%2C%20104819.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbc.2023.104819%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbc.2023.104819%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3D4URLGRL3%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20NSs%20protein%20of%20severe%20fever%20with%20thrombocytopenia%20syndrome%20virus%20differentially%20inhibits%20the%20type%201%20interferon%20response%20among%20animal%20species%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rokusuke%22%2C%22lastName%22%3A%22Yoshikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masahiro%22%2C%22lastName%22%3A%22Kawakami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiro%22%2C%22lastName%22%3A%22Yasuda%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-05-13%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbc.2023.104819%22%2C%22ISSN%22%3A%2200219258%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0021925823018471%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-12T05%3A21%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22ESPA25BE%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nabeshima%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-27%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENabeshima%2C%20T.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20Thuy%2C%20N.%20T.%20T.%2C%20Hang%2C%20N.%20L.%20K.%2C%20Mai%2C%20L.%20T.%20Q.%2C%20Hasebe%2C%20F.%2C%20Takamatsu%2C%20Y.%2C%20%26amp%3B%20Nagasaki%20University%20Vietnam%20Research%20Group.%20%282023%29.%20An%20outbreak%20of%20a%20novel%20lineage%20of%20dengue%20virus%202%20in%20Vietnam%20in%202022.%20%3Ci%3EJournal%20of%20Medical%20Virology%3C%5C%2Fi%3E%2C%20%3Ci%3E95%3C%5C%2Fi%3E%2811%29%2C%20e29255.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjmv.29255%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjmv.29255%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DESPA25BE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20outbreak%20of%20a%20novel%20lineage%20of%20dengue%20virus%202%20in%20Vietnam%20in%202022%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Nabeshima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nguyen%20Thi%20Thu%22%2C%22lastName%22%3A%22Thuy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nguyen%20Le%20Khanh%22%2C%22lastName%22%3A%22Hang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Le%20Thi%20Quynh%22%2C%22lastName%22%3A%22Mai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Futoshi%22%2C%22lastName%22%3A%22Hasebe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Nagasaki%20University%20Vietnam%20Research%20Group%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20In%202022%2C%20a%20large%20dengue%20outbreak%20was%20reported%20in%20Vietnam%2C%20where%20dengue%20was%20endemic.%20A%20total%20of%201889%20acute%5Cu2010phase%20serum%20samples%20were%20collected%20from%20patients%20with%20suspected%20dengue%20at%20Vung%20Tau%20General%20Hospital%2C%20the%20core%20hospital%20in%20Vung%20Tau%20Province%2C%20southern%20Vietnam.%20Among%20the%201889%20samples%20analyzed%20for%20laboratory%20confirmation%20of%20dengue%20virus%20%28DENV%29%20infection%2C%20339%20positive%20cases%20were%20identified%2C%20of%20which%20130%20were%20primary%20infections%20and%20209%20were%20secondary%20infections.%20DENV%5Cu20102%20was%20the%20dominant%20serotype%20in%20both%20primary%20and%20secondary%20infection%20groups.%20Phylogenetic%20analysis%20based%20on%20sequences%20of%20the%20envelope%20protein%5Cu2010coding%20region%20revealed%20the%20emergence%20of%20a%20new%20DENV%5Cu20102%20lineage%20during%20this%20outbreak.%22%2C%22date%22%3A%222023-11-27%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2Fjmv.29255%22%2C%22ISSN%22%3A%220146-6615%2C%201096-9071%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2F10.1002%5C%2Fjmv.29255%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-12T05%3A20%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22BT59N3U9%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fu%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFu%2C%20H.%2C%20Abbas%2C%20K.%2C%20Malvolti%2C%20S.%2C%20Gregory%2C%20C.%2C%20Ko%2C%20M.%2C%20Amorij%2C%20J.-P.%2C%20%26amp%3B%20Jit%2C%20M.%20%282023%29.%20Impact%20and%20cost-effectiveness%20of%20measles%20vaccination%20through%20microarray%20patches%20in%2070%20low-income%20and%20middle-income%20countries%3A%20mathematical%20modelling%20and%20early-stage%20economic%20evaluation.%20%3Ci%3EBMJ%20Global%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E8%3C%5C%2Fi%3E%2811%29%2C%20e012204.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2023-012204%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2023-012204%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DBT59N3U9%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20and%20cost-effectiveness%20of%20measles%20vaccination%20through%20microarray%20patches%20in%2070%20low-income%20and%20middle-income%20countries%3A%20mathematical%20modelling%20and%20early-stage%20economic%20evaluation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Han%22%2C%22lastName%22%3A%22Fu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefano%22%2C%22lastName%22%3A%22Malvolti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Gregory%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Ko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Amorij%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Jit%22%7D%5D%2C%22abstractNote%22%3A%22Background%20Microarray%20patches%20%28MAPs%29%20are%20a%20promising%20technology%20being%20developed%20to%20reduce%20barriers%20to%20vaccine%20delivery%20based%20on%20needles%20and%20syringes%20%28N%26S%29.%20To%20address%20the%20evidence%20gap%20on%20the%20public%20health%20value%20of%20applying%20this%20potential%20technology%20to%20immunisation%20programmes%2C%20we%20evaluated%20the%20health%20impact%20on%20measles%20burden%20and%20cost-effectiveness%20of%20introducing%20measles-rubella%20MAPs%20%28MR-MAPs%29%20in%2070%20low-income%20and%20middle-income%20countries%20%28LMICs%29.%5CnMethods%20We%20used%20an%20age-structured%20dynamic%20model%20of%20measles%20transmission%20and%20vaccination%20to%20project%20measles%20cases%2C%20deaths%20and%20disability-adjusted%20life-years%20during%202030%5Cu20132040.%20Compared%20with%20the%20baseline%20scenarios%20with%20continuing%20current%20N%26S-based%20practice%2C%20we%20evaluated%20the%20introduction%20of%20MR-MAPs%20under%20different%20measles%20vaccine%20coverage%20projections%20and%20MR-MAP%20introduction%20strategies.%20Costs%20were%20calculated%20based%20on%20the%20ingredients%20approach%2C%20including%20direct%20cost%20of%20measles%20treatment%2C%20vaccine%20procurement%20and%20vaccine%20delivery.%20Model-based%20burden%20and%20cost%20estimates%20were%20derived%20for%20individual%20countries%20and%20country%20income%20groups.%20We%20compared%20the%20incremental%20cost-effectiveness%20ratios%20of%20introducing%20MR-MAPs%20to%20health%20opportunity%20costs.%5CnResults%20MR-MAP%20introduction%20could%20prevent%2027%25%5Cu201337%25%20of%20measles%20burden%20between%202030%20and%202040%20in%2070%20LMICs%2C%20compared%20with%20the%20N%26S-only%20immunisation%20strategy.%20The%20largest%20health%20impact%20could%20be%20achieved%20under%20lower%20coverage%20projection%20and%20accelerated%20introduction%20strategy%2C%20with%2039%20million%20measles%20cases%20averted.%20Measles%20treatment%20cost%20is%20a%20key%20driver%20of%20the%20net%20cost%20of%20introduction.%20In%20countries%20with%20a%20relatively%20higher%20income%2C%20introducing%20MR-MAPs%20could%20be%20a%20cost-saving%20intervention%20due%20to%20reduced%20treatment%20costs.%20Compared%20with%20country-specific%20health%20opportunity%20costs%2C%20introducing%20MR-MAPs%20would%20be%20cost-effective%20in%2016%25%5Cu201381%25%20of%20LMICs%2C%20depending%20on%20the%20MR-MAPs%20procurement%20prices%20and%20vaccine%20coverage%20projections.%5CnConclusions%20Introducing%20MR-MAPs%20in%20LMICs%20can%20be%20a%20cost-effective%20strategy%20to%20revitalise%20measles%20immunisation%20programmes%20with%20stagnant%20uptake%20and%20reach%20undervaccinated%20children.%20Sustainable%20introduction%20and%20uptake%20of%20MR-MAPs%20has%20the%20potential%20to%20improve%20vaccine%20equity%20within%20and%20between%20countries%20and%20accelerate%20progress%20towards%20measles%20elimination.%22%2C%22date%22%3A%222023%5C%2F11%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2023-012204%22%2C%22ISSN%22%3A%222059-7908%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fgh.bmj.com%5C%2Fcontent%5C%2F8%5C%2F11%5C%2Fe012204%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-12T05%3A17%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22EGDMPVEK%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Flandes%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFlandes%2C%20X.%2C%20Hansen%2C%20C.%20A.%2C%20Palani%2C%20S.%2C%20Abbas%2C%20K.%2C%20Bennett%2C%20C.%2C%20Caro%2C%20W.%20P.%2C%20Hutubessy%2C%20R.%2C%20Khazhidinov%2C%20K.%2C%20Lambach%2C%20P.%2C%20Maure%2C%20C.%2C%20Marshall%2C%20C.%2C%20Rojas%2C%20D.%20P.%2C%20Rosewell%2C%20A.%2C%20Sahastrabuddhe%2C%20S.%2C%20Tufet%2C%20M.%2C%20Wilder-Smith%2C%20A.%2C%20Beasley%2C%20D.%20W.%20C.%2C%20Bourne%2C%20N.%2C%20%26amp%3B%20Barrett%2C%20A.%20D.%20T.%20%282023%29.%20Vaccine%20value%20profile%20for%20Chikungunya.%20%3Ci%3EVaccine%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.vaccine.2023.07.069%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.vaccine.2023.07.069%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DEGDMPVEK%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Vaccine%20value%20profile%20for%20Chikungunya%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ximena%22%2C%22lastName%22%3A%22Flandes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clairissa%20A.%22%2C%22lastName%22%3A%22Hansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunil%22%2C%22lastName%22%3A%22Palani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cate%22%2C%22lastName%22%3A%22Bennett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20Perea%22%2C%22lastName%22%3A%22Caro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%22%2C%22lastName%22%3A%22Hutubessy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kanat%22%2C%22lastName%22%3A%22Khazhidinov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%22%2C%22lastName%22%3A%22Lambach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Maure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Marshall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%20P.%22%2C%22lastName%22%3A%22Rojas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Rosewell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushant%22%2C%22lastName%22%3A%22Sahastrabuddhe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marta%22%2C%22lastName%22%3A%22Tufet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annelies%22%2C%22lastName%22%3A%22Wilder-Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20W.%20C.%22%2C%22lastName%22%3A%22Beasley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nigel%22%2C%22lastName%22%3A%22Bourne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%20D.%20T.%22%2C%22lastName%22%3A%22Barrett%22%7D%5D%2C%22abstractNote%22%3A%22Chikungunya%20virus%20%28CHIKV%29%20a%20mosquito-borne%20alphavirus%20is%20the%20causative%20agent%20of%20Chikungunya%20%28CHIK%29%2C%20a%20disease%20with%20low%20mortality%20but%20high%20acute%20and%20chronic%20morbidity%20resulting%20in%20a%20high%20overall%20burden%20of%20disease.%20After%20the%20acute%20disease%20phase%2C%20chronic%20disease%20including%20persistent%20arthralgia%20is%20very%20common%2C%20and%20can%20cause%20fatigue%20and%20pain%20that%20is%20severe%20enough%20to%20limit%20normal%20activities.%20On%20average%2C%20around%2040%25%20of%20people%20infected%20with%20CHIKV%20will%20develop%20chronic%20arthritis%2C%20which%20may%20last%20for%20months%20or%20years.%20Recommendations%20for%20protection%20from%20CHIKV%20focus%20on%20infection%20control%20through%20preventing%20mosquito%20proliferation.%20There%20is%20currently%20no%20licensed%20antiviral%20drug%20or%20vaccine%20against%20CHIKV.%20Therefore%2C%20one%20of%20the%20most%20important%20public%20health%20impacts%20of%20vaccination%20would%20be%20to%20decrease%20burden%20of%20disease%20and%20economic%20losses%20in%20areas%20impacted%20by%20the%20virus%2C%20and%20prevent%20or%20reduce%20chronic%20morbidity%20associated%20with%20CHIK.%20This%20benefit%20would%20particularly%20be%20seen%20in%20Low%20and%20Middle%20Income%20Countries%20%28LMIC%29%20and%20socio-economically%20deprived%20areas%2C%20as%20they%20are%20more%20likely%20to%20have%20more%20infections%20and%20more%20severe%20outcomes.%20This%20%5Cu2018Vaccine%20Value%20Profile%5Cu2019%20%28VVP%29%20for%20CHIK%20is%20intended%20to%20provide%20a%20high-level%2C%20holistic%20assessment%20of%20the%20information%20and%20data%20that%20are%20currently%20available%20to%20inform%20the%20potential%20public%20health%2C%20economic%20and%20societal%20value%20of%20vaccines%20in%20the%20development%20pipeline%20and%20vaccine-like%20products.This%20VVP%20was%20developed%20by%20a%20working%20group%20of%20subject%20matter%20experts%20from%20academia%2C%20non-profit%20organizations%2C%20public%20private%20partnerships%2C%20and%20multi-lateral%20organizations.%20All%20contributors%20have%20extensive%20expertise%20on%20various%20elements%20of%20the%20CHIK%20VVP%20and%20collectively%20aimed%20to%20identify%20current%20research%20and%20knowledge%20gaps.The%20VVP%20was%20developed%20using%20only%20existing%20and%20publicly%20available%20information.%22%2C%22date%22%3A%222023-11-10%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.vaccine.2023.07.069%22%2C%22ISSN%22%3A%220264-410X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0264410X23009155%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-12-12T05%3A17%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22Z5S784Z2%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Qian%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-14%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EQian%2C%20G.%20Y.%2C%20Edmunds%2C%20W.%20J.%2C%20Bausch%2C%20D.%20G.%2C%20%26amp%3B%20Jombart%2C%20T.%20%282023%29.%20A%20mathematical%20model%20of%20Marburg%20virus%20disease%20outbreaks%20and%20the%20potential%20role%20of%20vaccination%20in%20control.%20%3Ci%3EBMC%20Medicine%3C%5C%2Fi%3E%2C%20%3Ci%3E21%3C%5C%2Fi%3E%281%29%2C%20439.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12916-023-03108-x%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12916-023-03108-x%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DZ5S784Z2%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20mathematical%20model%20of%20Marburg%20virus%20disease%20outbreaks%20and%20the%20potential%20role%20of%20vaccination%20in%20control%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20Y.%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20John%22%2C%22lastName%22%3A%22Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20G.%22%2C%22lastName%22%3A%22Bausch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thibaut%22%2C%22lastName%22%3A%22Jombart%22%7D%5D%2C%22abstractNote%22%3A%22Marburg%20virus%20disease%20is%20an%20acute%20haemorrhagic%20fever%20caused%20by%20Marburg%20virus.%20Marburg%20virus%20is%20zoonotic%2C%20maintained%20in%20nature%20in%20Egyptian%20fruit%20bats%2C%20with%20occasional%20spillover%20infections%20into%20humans%20and%20nonhuman%20primates.%20Although%20rare%2C%20sporadic%20cases%20and%20outbreaks%20occur%20in%20Africa%2C%20usually%20associated%20with%20exposure%20to%20bats%20in%20mines%20or%20caves%2C%20and%20sometimes%20with%20secondary%20human-to-human%20transmission.%20Outbreaks%20outside%20of%20Africa%20have%20also%20occurred%20due%20to%20importation%20of%20infected%20monkeys.%20Although%20all%20previous%20Marburg%20virus%20disease%20outbreaks%20have%20been%20brought%20under%20control%20without%20vaccination%2C%20there%20is%20nevertheless%20the%20potential%20for%20large%20outbreaks%20when%20implementation%20of%20public%20health%20measures%20is%20not%20possible%20or%20breaks%20down.%20Vaccines%20could%20thus%20be%20an%20important%20additional%20tool%2C%20and%20development%20of%20several%20candidate%20vaccines%20is%20under%20way.%22%2C%22date%22%3A%222023-11-14%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12916-023-03108-x%22%2C%22ISSN%22%3A%221741-7015%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12916-023-03108-x%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-27T01%3A30%3A27Z%22%7D%7D%2C%7B%22key%22%3A%225W3FCJG8%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Furuse%22%2C%22parsedDate%22%3A%222023-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFuruse%2C%20Y.%20%282023%29.%20Estimation%20of%20excess%20cardiovascular%20deaths%20after%20COVID-19%20in%202020.%20%3Ci%3EThe%20Journal%20of%20Infection%3C%5C%2Fi%3E%2C%20%3Ci%3E87%3C%5C%2Fi%3E%281%29%2C%20e5%26%23x2013%3Be7.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jinf.2023.04.014%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jinf.2023.04.014%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3D5W3FCJG8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimation%20of%20excess%20cardiovascular%20deaths%20after%20COVID-19%20in%202020%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Furuse%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-7%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jinf.2023.04.014%22%2C%22ISSN%22%3A%220163-4453%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC10125210%5C%2F%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-05T08%3A05%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22X6MU5AKH%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Kyaw%2C%20A.%20K.%2C%20Nabeshima%2C%20T.%2C%20Dumre%2C%20S.%20P.%2C%20Soe%2C%20A.%20M.%2C%20Nwe%2C%20K.%20M.%2C%20Myaing%2C%20S.%20S.%2C%20Lwin%2C%20E.%20P.%2C%20Win%2C%20Y.%20T.%2C%20Inoue%2C%20S.%2C%20Takamatsu%2C%20Y.%2C%20Urano%2C%20T.%2C%20Thu%2C%20H.%20M.%2C%20Thant%2C%20K.%20Z.%2C%20Htun%2C%20Z.%20T.%2C%20%26amp%3B%20Morita%2C%20K.%20%282023%29.%20Coinfection%20and%20circulation%20of%20chikungunya%20virus%20and%20dengue%20virus%20in%20pediatric%20patients%20in%20Myanmar%2C%202019.%20%3Ci%3EMicrobes%20and%20Infection%3C%5C%2Fi%3E%2C%20%3Ci%3E25%3C%5C%2Fi%3E%286%29%2C%20105129.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.micinf.2023.105129%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.micinf.2023.105129%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DX6MU5AKH%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Coinfection%20and%20circulation%20of%20chikungunya%20virus%20and%20dengue%20virus%20in%20pediatric%20patients%20in%20Myanmar%2C%202019%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aung%20Kyaw%22%2C%22lastName%22%3A%22Kyaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Nabeshima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%20Prakash%22%2C%22lastName%22%3A%22Dumre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aung%20Min%22%2C%22lastName%22%3A%22Soe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khine%20Mya%22%2C%22lastName%22%3A%22Nwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%20Su%22%2C%22lastName%22%3A%22Myaing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ei%20Phyu%22%2C%22lastName%22%3A%22Lwin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ye%20Thu%22%2C%22lastName%22%3A%22Win%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hlaing%20Myat%22%2C%22lastName%22%3A%22Thu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyaw%20Zin%22%2C%22lastName%22%3A%22Thant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zaw%20Than%22%2C%22lastName%22%3A%22Htun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Myanmar%20is%20an%20endemic%20country%20for%20arboviruses%2C%20and%20outbreaks%20occur%20frequently.%20A%20cross-sectional%20analytical%20study%20was%20conducted%20during%20the%20peak%20season%20of%20the%20chikungunya%20virus%20%28CHIKV%29%20outbreak%20in%202019.%20A%20total%20of%20201%20patients%20with%20acute%20febrile%20illness%20who%20were%20admitted%20to%20the%20550-bedded%20Mandalay%20Children%20Hospital%20in%20Myanmar%20were%20enrolled%20in%20the%20study%2C%20and%20virus%20isolation%2C%20serological%20tests%2C%20and%20molecular%20tests%20for%20the%20dengue%20virus%20%28DENV%29%20and%20CHIKV%20were%20performed%20for%20all%20samples.%20Out%20of%20201%20patients%2C%2071%20%2835.3%25%29%20were%20only%20DENV-infected%2C%2030%20%2814.9%25%29%20were%20only%20CHIKV-infected%20and%2059%20%2829.4%25%29%20were%20coinfected%20with%20DENV%20and%20CHIKV.%20The%20viremia%20levels%20of%20the%20DENV-%20and%20CHIKV-%20mono-infected%20groups%20were%20significantly%20higher%20than%20those%20of%20the%20group%20coinfected%20with%20DENV%20and%20CHIKV.%20Genotype%20I%20of%20DENV-1%2C%20genotypes%20I%20and%20III%20of%20DENV-3%2C%20genotype%20I%20of%20DENV-4%20and%20the%20East%5C%2FCentral%5C%2FSouth%20African%20genotype%20of%20CHIKV%20were%20co-circulating%20during%20the%20study%20period.%20Two%20novel%20epistatic%20mutations%20of%20CHIKV%20%28E1%3AK211E%20and%20E2%3AV264A%29%20were%20noted.%20This%20study%20highlighted%20that%20there%20were%20many%20coinfection%20cases%20during%20the%20outbreak%20and%20that%20the%20co-circulation%20of%20both%20viruses%20in%20DENV-endemic%20regions%20warrants%20effective%20monitoring%20of%20these%20emerging%20pathogens%20via%20comprehensive%20surveillance%20to%20facilitate%20the%20implementation%20of%20effective%20control%20measures.%22%2C%22date%22%3A%222023-07-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.micinf.2023.105129%22%2C%22ISSN%22%3A%221286-4579%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1286457923000321%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-05T08%3A05%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22KUTU6XIU%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rimal%20et%20al.%22%2C%22parsedDate%22%3A%222023-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERimal%2C%20S.%2C%20Shrestha%2C%20S.%2C%20Pandey%2C%20K.%2C%20Nguyen%2C%20T.%20V.%2C%20Bhandari%2C%20P.%2C%20Shah%2C%20Y.%2C%20Acharya%2C%20D.%2C%20Adhikari%2C%20N.%2C%20Rijal%2C%20K.%20R.%2C%20Ghimire%2C%20P.%2C%20Takamatsu%2C%20Y.%2C%20Pandey%2C%20B.%20D.%2C%20Fernandez%2C%20S.%2C%20Morita%2C%20K.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20%26amp%3B%20Dumre%2C%20S.%20P.%20%282023%29.%20Co-Circulation%20of%20Dengue%20Virus%20Serotypes%201%2C%202%2C%20and%203%20during%20the%202022%20Dengue%20Outbreak%20in%20Nepal%3A%20A%20Cross-Sectional%20Study.%20%3Ci%3EViruses%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%282%29%2C%20507.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv15020507%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv15020507%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DKUTU6XIU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Co-Circulation%20of%20Dengue%20Virus%20Serotypes%201%2C%202%2C%20and%203%20during%20the%202022%20Dengue%20Outbreak%20in%20Nepal%3A%20A%20Cross-Sectional%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandesh%22%2C%22lastName%22%3A%22Rimal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabin%22%2C%22lastName%22%3A%22Shrestha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kishor%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thanh%20Vu%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parmananda%22%2C%22lastName%22%3A%22Bhandari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yogendra%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Acharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabaraj%22%2C%22lastName%22%3A%22Adhikari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Komal%20Raj%22%2C%22lastName%22%3A%22Rijal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prakash%22%2C%22lastName%22%3A%22Ghimire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basu%20Dev%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Fernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%20Prakash%22%2C%22lastName%22%3A%22Dumre%22%7D%5D%2C%22abstractNote%22%3A%22The%20largest%20dengue%20outbreak%20in%20the%20history%20of%20Nepal%20occurred%20in%202022%2C%20with%20a%20significant%20number%20of%20casualties.%20It%20affected%20all%2077%20districts%2C%20with%20the%20nation%5Cu2019s%20capital%2C%20Kathmandu%20%28altitude%201300%20m%29%2C%20being%20the%20hardest%20hit.%20However%2C%20the%20molecular%20epidemiology%20of%20this%20outbreak%2C%20including%20the%20dengue%20virus%20%28DENV%29%20serotype%28s%29%20responsible%20for%20this%20epidemic%2C%20remain%20unknown.%20Here%2C%20we%20report%20the%20epidemic%20trends%2C%20clinico-laboratory%20features%2C%20and%20virus%20serotypes%20and%20their%20viral%20load%20profiles%20that%20are%20associated%20with%20this%20outbreak%20in%20Nepal.%20Dengue-suspected%20febrile%20patients%20were%20investigated%20by%20routine%20laboratory%2C%20serological%2C%20and%20molecular%20tools%2C%20including%20a%20real-time%20quantitative%20polymerase%20chain%20reaction%20%28qRT-PCR%29.%20Of%20the%20538%20dengue-suspected%20patients%20enrolled%2C%20401%20%2874.5%25%29%20were%20diagnosed%20with%20dengue.%20Among%20these%20dengue%20cases%2C%20129%20%2832.2%25%29%20patients%20who%20required%20hospital%20admission%20had%20significant%20associations%20with%20myalgia%2C%20rash%2C%20diarrhea%2C%20retro-orbital%20pain%2C%20bleeding%2C%20and%20abdominal%20pain.%20DENV-1%2C%20-2%2C%20and%20-3%20were%20identified%20during%20the%202022%20epidemic%2C%20with%20a%20predominance%20of%20DENV-1%20%2857.1%25%29%20and%20DENV-3%20%2832.1%25%29%2C%20exhibiting%20a%20new%20serotype%20addition.%20We%20found%20that%20multiple%20serotypes%20circulated%20in%202022%2C%20with%20a%20higher%20frequency%20of%20hospitalizations%2C%20more%20severe%20dengue%2C%20and%20more%20deaths%20than%20in%20the%20past.%20Therefore%2C%20precise%20mapping%20of%20dengue%20and%20other%20related%20infections%20through%20integrated%20disease%20surveillance%2C%20evaluation%20of%20the%20dynamics%20of%20population-level%20immunity%20and%20virus%20evolution%20should%20be%20the%20urgent%20plans%20of%20action%20for%20evidence-based%20policy-making%20for%20dengue%20control%20and%20prevention%20in%20the%20country.%22%2C%22date%22%3A%222023%5C%2F2%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fv15020507%22%2C%22ISSN%22%3A%221999-4915%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1999-4915%5C%2F15%5C%2F2%5C%2F507%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-05T08%3A03%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22JFE9M3EU%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Furuse%22%2C%22parsedDate%22%3A%222023-01-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFuruse%2C%20Y.%20%282023%29.%20Cartography%20of%20SARS-CoV-2%20variants%20based%20on%20the%20susceptibility%20to%20therapeutic%20monoclonal%20antibodies.%20%3Ci%3EJournal%20of%20Medical%20Virology%3C%5C%2Fi%3E%2C%20%3Ci%3E95%3C%5C%2Fi%3E%281%29%2C%20e28275.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjmv.28275%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjmv.28275%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DJFE9M3EU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cartography%20of%20SARS-CoV-2%20variants%20based%20on%20the%20susceptibility%20to%20therapeutic%20monoclonal%20antibodies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Furuse%22%7D%5D%2C%22abstractNote%22%3A%22A%20comprehensive%20picture%20of%20a%20phenotypic%20relationship%20among%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20%28SARS-CoV-2%29%20variants%20has%20been%20poorly%20studied.%20Here%2C%20this%20study%20presents%20cartography%20showing%20how%20the%20wild-type%20strain%20of%20SARS-CoV-2%20and%2014%20variants%20are%20alike%20or%20different%20from%20the%20perspective%20of%20the%20susceptibility%20to%2012%20therapeutic%20monoclonal%20antibodies.%20The%20Alpha%20variant%20is%20close%20to%20the%20wild-type%20strain%2C%20whereas%20the%20Beta%2C%20Gamma%2C%20and%20Delta%20variants%20diverge%20from%20the%20wild-type.%20The%20map%20highlights%20the%20very%20unique%20property%20of%20the%20Omicron%20variant.%20Interestingly%2C%20sublineages%20of%20the%20Omicron%20variants%2C%20BA.1%2C%20BA.2%2C%20and%20BA.4%5C%2F5%2C%20differ%20substantially%20in%20the%20cartography.%22%2C%22date%22%3A%222023-01-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjmv.28275%22%2C%22ISSN%22%3A%221096-9071%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Feuropepmc.org%5C%2Farticles%5C%2FPMC9877944%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-05T08%3A02%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22B99WV6S8%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Qian%20et%20al.%22%2C%22parsedDate%22%3A%222023-08-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EQian%2C%20G.%20Y.%2C%20Jombart%2C%20T.%2C%20%26amp%3B%20John%20Edmunds%2C%20W.%20%282023%29.%20Assessing%20the%20feasibility%20of%20Phase%203%20vaccine%20trials%20against%20Marburg%20Virus%20Disease%3A%20A%20modelling%20study.%20%3Ci%3EVaccine%3A%20X%3C%5C%2Fi%3E%2C%20%3Ci%3E14%3C%5C%2Fi%3E%2C%20100321.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvacx.2023.100321%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvacx.2023.100321%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DB99WV6S8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Assessing%20the%20feasibility%20of%20Phase%203%20vaccine%20trials%20against%20Marburg%20Virus%20Disease%3A%20A%20modelling%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20Y.%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thibaut%22%2C%22lastName%22%3A%22Jombart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22John%20Edmunds%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnOutbreaks%20of%20Marburg%20virus%20disease%20%28MVD%29%20are%20rare%20and%20small%20in%20size%2C%20with%20only%2018%20recorded%20outbreaks%20since%201967%2C%20only%20two%20of%20which%20involved%20more%20than%20100%20cases.%20It%20has%20been%20proposed%2C%20therefore%2C%20that%20Phase%203%20trials%20for%20MVD%20vaccines%20should%20be%20held%20open%20over%20multiple%20outbreaks%20until%20sufficient%20end%20points%20accrue%20to%20enable%20vaccine%20efficacy%20%28VE%29%20to%20be%20calculated.%20Here%20we%20estimate%20how%20many%20outbreaks%20might%20be%20needed%20for%20VE%20to%20be%20estimated.%5CnMethods%5CnWe%20adapt%20a%20mathematical%20model%20of%20MVD%20transmission%20to%20simulate%20a%20Phase%203%20individually%20randomised%20placebo%20controlled%20vaccine%20trial.%20We%20assume%20in%20the%20base%20case%20that%20vaccine%20efficacy%20is%2070%25%20and%20that%2050%25%20of%20individuals%20in%20affected%20areas%20are%20enrolled%20into%20the%20trial%20%281%3A1%20randomisation%29.%20We%20further%20assume%20that%20the%20vaccine%20trial%20starts%20two%20weeks%20after%20public%20health%20interventions%20are%20put%20in%20place%20and%20that%20cases%20occurring%20within%2010%5Cu00a0days%20of%20vaccination%20are%20not%20included%20in%20VE%20calculations.%5CnResults%5CnThe%20median%20size%20of%20simulated%20outbreaks%20was%202%20cases.%20Only%200.3%25%20of%20simulated%20outbreaks%20were%20predicted%20to%20have%20more%20than%20100%20MVD%20cases.%2095%25%20of%20simulated%20outbreaks%20terminated%20before%20cases%20accrued%20in%20the%20placebo%20and%20vaccine%20arms.%20Therefore%20the%20number%20of%20outbreaks%20required%20to%20estimate%20VE%20was%20large%3A%20after%20100%20outbreaks%2C%20the%20estimated%20VE%20was%2069%25%20but%20with%20considerable%20uncertainty%20%2895%25%20CIs%3A%200%25%5Cu2212100%25%29%20while%20the%20estimated%20VE%20after%20200%20outbreaks%20was%2067%25%20%2895%25%20CIs%3A%2042%25%5Cu221285%25%29.%20Altering%20base-case%20assumptions%20made%20little%20difference%20to%20the%20findings.%20In%20a%20sensitivity%20analysis%2C%20increasing%20R0%20by%2025%25%20and%2050%25%20led%20to%20an%20estimated%20VE%20after%20200%20outbreaks%20of%2069%25%20%2895%25%20CIs%3A%2053%5Cu201385%25%29%20and%2070%25%20%2895%25%20CIs%3A%2059%5Cu201382%25%29%2C%20respectively.%5CnConclusions%5CnIt%20is%20unlikely%20that%20the%20efficacy%20of%20any%20candidate%20vaccine%20can%20be%20calculated%20before%20more%20MVD%20outbreaks%20have%20occurred%20than%20have%20been%20recorded%20to%20date.%20This%20is%20because%20MVD%20outbreaks%20tend%20to%20be%20small%2C%20public%20health%20interventions%20have%20been%20historically%20effective%20at%20reducing%20transmission%2C%20and%20vaccine%20trials%20are%20only%20likely%20to%20start%20after%20these%20interventions%20are%20already%20in%20place.%20Hence%2C%20it%20is%20expected%20that%20outbreaks%20will%20terminate%20before%2C%20or%20shortly%20after%2C%20cases%20start%20to%20accrue%20in%20the%20vaccine%20and%20placebo%20arms.%22%2C%22date%22%3A%222023-08-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jvacx.2023.100321%22%2C%22ISSN%22%3A%222590-1362%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS2590136223000621%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-05T07%3A58%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22CB8JK333%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nguyen%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENguyen%2C%20T.%20V.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20Cao%2C%20M.%20T.%2C%20Dao%2C%20H.%20M.%2C%20Luong%2C%20C.%20Q.%2C%20Huynh%2C%20T.%20K.%20L.%2C%20Nguyen%2C%20T.%20T.%20T.%2C%20Hoang%2C%20T.%20N.%20D.%2C%20Morita%2C%20K.%2C%20Le%2C%20T.%20Q.%20M.%2C%20Pham%2C%20Q.%20D.%2C%20Takamatsu%2C%20Y.%2C%20%26amp%3B%20Hasebe%2C%20F.%20%282023%29.%20Serological%20and%20Molecular%20Epidemiology%20of%20Chikungunya%20Virus%20Infection%20in%20Vietnam%2C%202017-2019.%20%3Ci%3EViruses%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%2810%29%2C%202065.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv15102065%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv15102065%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DCB8JK333%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Serological%20and%20Molecular%20Epidemiology%20of%20Chikungunya%20Virus%20Infection%20in%20Vietnam%2C%202017-2019%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thanh%20Vu%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minh%20Thang%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huy%20Manh%22%2C%22lastName%22%3A%22Dao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chan%20Quang%22%2C%22lastName%22%3A%22Luong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Kim%20Loan%22%2C%22lastName%22%3A%22Huynh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thanh%20Thuong%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Nhu%20Dao%22%2C%22lastName%22%3A%22Hoang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Quynh%20Mai%22%2C%22lastName%22%3A%22Le%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Quang%20Duy%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Futoshi%22%2C%22lastName%22%3A%22Hasebe%22%7D%5D%2C%22abstractNote%22%3A%22Chikungunya%20fever%20is%20an%20acute%20febrile%20illness%20caused%20by%20the%20chikungunya%20virus%20%28CHIKV%29%2C%20which%20is%20transmitted%20by%20Aedes%20mosquitoes.%20Since%201965%2C%20only%20a%20few%20studies%20with%20limited%20scope%20have%20been%20conducted%20on%20CHIKV%20in%20Vietnam.%20Thus%2C%20this%20study%20aimed%20to%20determine%20the%20seroprevalence%20and%20molecular%20epidemiology%20of%20CHIKV%20infection%20among%20febrile%20patients%20in%20Vietnam%20from%202017%20to%202019.%20A%20total%20of%201063%20serum%20samples%20from%2031%20provinces%20were%20collected%20and%20tested%20for%20anti-CHIKV%20IgM%20and%20IgG%20ELISA.%20The%2050%25%20focus%20reduction%20neutralization%20test%20%28FRNT50%29%20was%20used%20to%20confirm%20CHIKV-neutralizing%20antibodies.%20Quantitative%20real-time%20RT-PCR%20%28RT-qPCR%29%20was%20performed%20to%20confirm%20the%20presence%20of%20the%20CHIKV%20genome.%20The%20results%20showed%20that%2015.9%25%20%28169%5C%2F1063%29%20of%20the%20patients%20had%20anti-CHIKV%20IgM%20antibodies%2C%2020.1%25%20%28214%5C%2F1063%29%20had%20anti-CHIKV%20IgG%20antibodies%2C%2010.4%25%20%28111%5C%2F1063%29%20had%20CHIKV-neutralizing%20antibodies%2C%20and%2027.7%25%20%28130%5C%2F469%29%20of%20the%20samples%20were%20positive%20in%20RT-qPCR%20analysis.%20The%20E1%20CHIKV%20genome%20sequences%20were%20detected%20among%20the%20positive%20RT-qPCR%20samples.%20Our%20identified%20sequences%20belonged%20to%20the%20East%5C%2FCentral%5C%2FSouth%5C%2FAfrican%20%28ECSA%29%20genotype%2C%20which%20has%20been%20prevalent%20in%20Vietnam%20previously%2C%20suggesting%20CHIKV%20has%20been%20maintained%20and%20is%20endemic%20in%20Vietnam.%20This%20study%20demonstrates%20a%20high%20prevalence%20of%20CHIKV%20infection%20in%20Vietnam%20and%20calls%20for%20an%20annual%20surveillance%20program%20to%20understand%20its%20impact.%22%2C%22date%22%3A%222023-10-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fv15102065%22%2C%22ISSN%22%3A%221999-4915%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-05T07%3A57%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22MAAIKHW3%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cadarette%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-30%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECadarette%2C%20D.%2C%20Ferranna%2C%20M.%2C%20Cannon%2C%20J.%20W.%2C%20Abbas%2C%20K.%2C%20Giannini%2C%20F.%2C%20Zucker%2C%20L.%2C%20%26amp%3B%20Bloom%2C%20D.%20E.%20%282023%29.%20The%20full%20health%2C%20economic%2C%20and%20social%20benefits%20of%20prospective%20Strep%20A%20vaccination.%20%3Ci%3ENpj%20Vaccines%3C%5C%2Fi%3E%2C%20%3Ci%3E8%3C%5C%2Fi%3E%281%29%2C%201%26%23x2013%3B9.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41541-023-00758-z%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41541-023-00758-z%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fdida.nagasaki-u.ac.jp%5C%2Fdida_wp%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D12924226%26amp%3Bitem_key%3DMAAIKHW3%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20full%20health%2C%20economic%2C%20and%20social%20benefits%20of%20prospective%20Strep%20A%20vaccination%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Cadarette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maddalena%22%2C%22lastName%22%3A%22Ferranna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20W.%22%2C%22lastName%22%3A%22Cannon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fiona%22%2C%22lastName%22%3A%22Giannini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Zucker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Bloom%22%7D%5D%2C%22abstractNote%22%3A%22Recent%20research%20has%20documented%20a%20wide%20range%20of%20health%2C%20economic%2C%20and%20social%20benefits%20conferred%20by%20vaccination%2C%20beyond%20the%20direct%20reductions%20in%20morbidity%2C%20mortality%2C%20and%20future%20healthcare%20costs%20traditionally%20captured%20in%20economic%20evaluations.%20In%20this%20paper%2C%20we%20describe%20the%20societal%20benefits%20that%20would%20likely%20stem%20from%20widespread%20administration%20of%20safe%20and%20effective%20vaccines%20against%20Streptococcus%20pyogenes%20%28Strep%20A%29%2C%20which%20was%20estimated%20to%20be%20the%20fifth-leading%20cause%20of%20infectious%20disease%20deaths%20globally%20prior%20to%20the%20COVID-19%20pandemic.%20We%20then%20estimate%20the%20global%20societal%20gains%20from%20prospective%20Strep%20A%20vaccination%20through%20a%20value-per-statistical-life%20approach.%20Estimated%20aggregate%20lifetime%20benefits%20for%2030%20global%20birth%20cohorts%20range%20from%20%241.7%20to%20%245.1%20trillion%2C%20depending%20on%20the%20age%20at%20which%20vaccination%20is%20administered%20and%20other%20factors.%20These%20results%20suggest%20that%20the%20benefits%20of%20Strep%20A%20vaccination%20would%20be%20large%20and%20justify%20substantial%20investment%20in%20the%20vaccines%5Cu2019%20development%2C%20manufacture%2C%20and%20delivery.%22%2C%22date%22%3A%222023-10-30%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41541-023-00758-z%22%2C%22ISSN%22%3A%222059-0105%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41541-023-00758-z%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-11-05T07%3A56%3A46Z%22%7D%7D%5D%7D
Ngwe Tun, M. M., Kapandji, M., Wada, A., Yamamoto, K., Dumre, S. P., Nwe, K. M., Lin, H., Takamatsu, Y., Thant, K. Z., Thu, H. M., Urano, T., Pandey, B. D., & Morita, K. (2024). Performance of Fujifilm Dengue NS1 Antigen Rapid Diagnosis Kit Compared to Quantitative Real-Time Polymerase Chain Reaction. Pathogens, 13(9), 818. https://doi.org/10.3390/pathogens13090818 Cite
Kulma, I., Na-Bangchang, K., Carvallo Herrera, A., Ndubuisi, I. T., Iwasaki, M., Tomono, H., Morita, C. T., Okamura, H., Mukae, H., & Tanaka, Y. (2024). Analysis of the Effector Functions of Vδ2 γδ T Cells and NK Cells against Cholangiocarcinoma Cells. Cells, 13(16), 1322. https://doi.org/10.3390/cells13161322 Cite
Ondo, G., Ushijima, Y., Abe, H., Mahmoudou, S., Bikangui, R., Nkoma, A., Mbadinga, M., More, A., Agbanrin, M., Pemba, C., Beh Mba, R., Adegnika, A. A., Lell, B., & Yasuda, J. (2024). Genetic Diversity and Detection of Respiratory Viruses Excluding SARS-CoV-2 during the COVID-19 Pandemic in Gabon, 2020–2021. Viruses, 16(5), 698. https://doi.org/10.3390/v16050698 Cite
Hoa-Tran, T. N., Nakagomi, T., Vu, H. M., Nguyen, T. T. T., Dao, A. T. H., Nguyen, A. T., Bines, J. E., Thomas, S., Grabovac, V., Kataoka-Nakamura, C., Taichiro, T., Hasebe, F., Kodama, T., Kaneko, M., Dang, H. T. T., Duong, H. T., Anh, D. D., & Nakagomi, O. (2024). Evolution of DS-1-like G8P[8] rotavirus A strains from Vietnamese children with acute gastroenteritis (2014–21): Adaptation and loss of animal rotavirus-derived genes during human-to-human spread. Virus Evolution, 10(1), veae045. https://doi.org/10.1093/ve/veae045 Cite
Mogasale, V., Sinha, A., John, J., Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Dhoubhadel, B. G., Edmunds, W. J., Clark, A. D., & Abbas, K. (2024). Typhoid Conjugate Vaccine Implementation in India: A Review of Supportive Evidence (SSRN Scholarly Paper No. 4870785). https://doi.org/10.2139/ssrn.4870785 Cite
Murayama, H., Endo, A., & Yonekura, S. (2023). Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics, 45, 100726. https://doi.org/10.1016/j.epidem.2023.100726 Cite
Ngwe Tun, M. M., Luvai, E. A. C., Toizumi, M., Moriuchi, M., Takamatsu, Y., Inoue, S., Urano, T., Bui, M. X., Thai Hung, D., Thi Nguyen, H.-A., Anh, D. D., Yoshida, L.-M., Moriuchi, H., & Morita, K. (2024). Possible vertical transmission of Chikungunya virus infection detected in the cord blood samples from a birth cohort in Vietnam. Journal of Infection and Public Health, 17(6), 1050–1056. https://doi.org/10.1016/j.jiph.2024.04.012 Cite
Asakura, T. R., Jung, S., Murayama, H., Ghaznavi, C., Sakamoto, H., Teshima, A., Miura, F., & Endo, A. (2024). Projecting international mpox spread in Asia: ongoing global health risk. medRxiv. https://doi.org/10.1101/2024.04.17.24305832 Cite
Rimal, S., Shrestha, S., Paudel, S. W., Shah, Y., Bhandari, G., Pandey, K., Kharbuja, A., Kapandji, M., Gautam, I., Bhujel, R., Takamatsu, Y., Bhandari, R., Klungthong, C., Shrestha, S. K., Fernandez, S., Malavige, G. N., Pandey, B. D., Urano, T., Morita, K., … Dumre, S. P. (2024). Molecular and Entomological Characterization of 2023 Dengue Outbreak in Dhading District, Central Nepal. Viruses, 16(4), 594. https://doi.org/10.3390/v16040594 Cite
Hartner, A.-M., Li, X., Echeverria-Londono, S., Roth, J., Abbas, K., Auzenbergs, M., De Villiers, M. J., Ferrari, M. J., Fraser, K., Fu, H., Hallett, T., Hinsley, W., Jit, M., Karachaliou, A., Moore, S. M., Nayagam, S., Papadopoulos, T., Perkins, T. A., Portnoy, A., … Gaythorpe, K. A. M. (2024). Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study. The Lancet Global Health, 12(4), e563–e571. https://doi.org/10.1016/S2214-109X(23)00603-4 Cite
Kang, H., Auzenbergs, M., Clapham, H., Maure, C., Kim, J.-H., Salje, H., Taylor, C. G., Lim, A., Clark, A., Edmunds, W. J., Sahastrabuddhe, S., Brady, O. J., & Abbas, K. (2024). Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. The Lancet Infectious Diseases, S1473309923008101. https://doi.org/10.1016/S1473-3099(23)00810-1 Cite
Auzenbergs, M., Maure, C., Kang, H., Clark, A., Brady, O., Sahastrabuddhe, S., & Abbas, K. (2024). Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis. PLOS Neglected Tropical Diseases, 18(4), e0012075. https://doi.org/10.1371/journal.pntd.0012075 Cite
Williams, S. V., Akande, T., & Abbas, K. (2024). Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria. PLOS ONE, 19(3), e0297326. https://doi.org/10.1371/journal.pone.0297326 Cite
Abbas, K., Yoo, K. J., Prem, K., & Jit, M. (2024). Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study. EClinicalMedicine, 102524. https://doi.org/10.1016/j.eclinm.2024.102524 Cite
Ngwe Tun, M. M., Kyaw, A. K., Nwe, K. M., Myaing, S. S., Win, Y. T., Inoue, S., Takamatsu, Y., Urano, T., Thu, H. M., Hmone, S. W., Thant, K. Z., & Morita, K. (2023). Burden of Chikungunya Virus Infection during an Outbreak in Myanmar. Viruses, 15(8), 1734. https://doi.org/10.3390/v15081734 Cite
Balingit, J. C., Dimamay, M. P. S., Suzuki, R., Matsuda, M., Xayavong, D., Ngwe Tun, M. M., Matias, R. R., Natividad, F. F., Moi, M. L., Takamatsu, Y., Culleton, R., Buerano, C. C., & Morita, K. (2024). Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data. International Journal of Infectious Diseases, 139, 59–68. https://doi.org/10.1016/j.ijid.2023.11.025 Cite
Paul, K. M. M., Simpson, S. V., Nundu, S. S., Arima, H., & Yamamoto, T. (2024). Genetic diversity of glutamate-rich protein (GLURP) in Plasmodium falciparum isolates from school-age children in Kinshasa, DRC. Parasitology International, 100, 102866. https://doi.org/10.1016/j.parint.2024.102866 Cite
Mogasale, V., Sinha, A., John, J., Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Dhoubhadel, B. G., Edmunds, W. J., Clark, A. D., & Abbas, K. (2024). Research Priorities to Support Typhoid Conjugate Vaccine Decision-Making in India: Evidence Assessment and Stakeholder Survey (SSRN Scholarly Paper No. 4714399). https://doi.org/10.2139/ssrn.4714399 Cite
Parajulee, P., Lee, J.-S., Abbas, K., Cannon, J., Excler, J. L., Kim, J. H., & Mogasale, V. (2024). State transitions across the Strep A disease spectrum: scoping review and evidence gaps. BMC Infectious Diseases, 24(1), 108. https://doi.org/10.1186/s12879-023-08888-4 Cite
Naylor, N. R., Hasso-Agopsowicz, M., Kim, C., Ma, Y., Frost, I., Abbas, K., Aguilar, G., Fuller, N. M., Robotham, J. V., & Jit, M. (2023). The Global Economic Burden of Antibiotic Resistant Infections and the Potential Impact of Bacterial Vaccines: A Modelling Study (SSRN Scholarly Paper No. 4676946). https://doi.org/10.2139/ssrn.4676946 Cite
Murayama, H., Endo, A., & Yonekura, S. (2023). Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics, 45, 100726. https://doi.org/10.1016/j.epidem.2023.100726 Cite
Ngwe Tun, M. M., Raini, S. K., Fernando, L., Gunawardene, Y., Inoue, S., Takamatsu, Y., Urano, T., Muthugala, R., Hapugoda, M., & Morita, K. (2023). Epidemiological evidence of acute transmission of Zika virus infection in dengue suspected patients in Sri-Lanka. Journal of Infection and Public Health, 16(9), 1435–1442. https://doi.org/10.1016/j.jiph.2023.07.014 Cite
Nwe, K. M., Tun, M. M. N., Muthugala, R., Nabeshima, T., Balingit, J. C., Rajamanthri, L., Jayawardana, D., Attanayake, S., Inoue, S., Takamatsu, Y., Urano, T., & Morita, K. (2023). Clinical, Virological, and Immunological Features in Cosmopolitan Genotype DENV-2–Infected Patients during a Large Dengue Outbreak in Sri Lanka in 2017. The American Journal of Tropical Medicine and Hygiene, 109(4), 917–925. https://doi.org/10.4269/ajtmh.22-0780 Cite
Ngwe Tun, M. M., Nwe, K. M., Balingit, J. C., Takamatsu, Y., Inoue, S., Pandey, B. D., Urano, T., Kohara, M., Tsukiyama-Kohara, K., & Morita, K. (2023). A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis. Vaccines, 11(12), 1857. https://doi.org/10.3390/vaccines11121857 Cite
Furuse, Y. (2024). Characteristics of retracted research papers before and during the COVID-19 pandemic. Frontiers in Medicine, 10. https://www.frontiersin.org/articles/10.3389/fmed.2023.1288014 Cite
Yoshikawa, R., Kawakami, M., & Yasuda, J. (2023). The NSs protein of severe fever with thrombocytopenia syndrome virus differentially inhibits the type 1 interferon response among animal species. Journal of Biological Chemistry, 299(6), 104819. https://doi.org/10.1016/j.jbc.2023.104819 Cite
Nabeshima, T., Ngwe Tun, M. M., Thuy, N. T. T., Hang, N. L. K., Mai, L. T. Q., Hasebe, F., Takamatsu, Y., & Nagasaki University Vietnam Research Group. (2023). An outbreak of a novel lineage of dengue virus 2 in Vietnam in 2022. Journal of Medical Virology, 95(11), e29255. https://doi.org/10.1002/jmv.29255 Cite
Fu, H., Abbas, K., Malvolti, S., Gregory, C., Ko, M., Amorij, J.-P., & Jit, M. (2023). Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation. BMJ Global Health, 8(11), e012204. https://doi.org/10.1136/bmjgh-2023-012204 Cite
Flandes, X., Hansen, C. A., Palani, S., Abbas, K., Bennett, C., Caro, W. P., Hutubessy, R., Khazhidinov, K., Lambach, P., Maure, C., Marshall, C., Rojas, D. P., Rosewell, A., Sahastrabuddhe, S., Tufet, M., Wilder-Smith, A., Beasley, D. W. C., Bourne, N., & Barrett, A. D. T. (2023). Vaccine value profile for Chikungunya. Vaccine. https://doi.org/10.1016/j.vaccine.2023.07.069 Cite
Qian, G. Y., Edmunds, W. J., Bausch, D. G., & Jombart, T. (2023). A mathematical model of Marburg virus disease outbreaks and the potential role of vaccination in control. BMC Medicine, 21(1), 439. https://doi.org/10.1186/s12916-023-03108-x Cite
Furuse, Y. (2023). Estimation of excess cardiovascular deaths after COVID-19 in 2020. The Journal of Infection, 87(1), e5–e7. https://doi.org/10.1016/j.jinf.2023.04.014 Cite
Ngwe Tun, M. M., Kyaw, A. K., Nabeshima, T., Dumre, S. P., Soe, A. M., Nwe, K. M., Myaing, S. S., Lwin, E. P., Win, Y. T., Inoue, S., Takamatsu, Y., Urano, T., Thu, H. M., Thant, K. Z., Htun, Z. T., & Morita, K. (2023). Coinfection and circulation of chikungunya virus and dengue virus in pediatric patients in Myanmar, 2019. Microbes and Infection, 25(6), 105129. https://doi.org/10.1016/j.micinf.2023.105129 Cite
Rimal, S., Shrestha, S., Pandey, K., Nguyen, T. V., Bhandari, P., Shah, Y., Acharya, D., Adhikari, N., Rijal, K. R., Ghimire, P., Takamatsu, Y., Pandey, B. D., Fernandez, S., Morita, K., Ngwe Tun, M. M., & Dumre, S. P. (2023). Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study. Viruses, 15(2), 507. https://doi.org/10.3390/v15020507 Cite
Furuse, Y. (2023). Cartography of SARS-CoV-2 variants based on the susceptibility to therapeutic monoclonal antibodies. Journal of Medical Virology, 95(1), e28275. https://doi.org/10.1002/jmv.28275 Cite
Qian, G. Y., Jombart, T., & John Edmunds, W. (2023). Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: A modelling study. Vaccine: X, 14, 100321. https://doi.org/10.1016/j.jvacx.2023.100321 Cite
Nguyen, T. V., Ngwe Tun, M. M., Cao, M. T., Dao, H. M., Luong, C. Q., Huynh, T. K. L., Nguyen, T. T. T., Hoang, T. N. D., Morita, K., Le, T. Q. M., Pham, Q. D., Takamatsu, Y., & Hasebe, F. (2023). Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017-2019. Viruses, 15(10), 2065. https://doi.org/10.3390/v15102065 Cite
Cadarette, D., Ferranna, M., Cannon, J. W., Abbas, K., Giannini, F., Zucker, L., & Bloom, D. E. (2023). The full health, economic, and social benefits of prospective Strep A vaccination. Npj Vaccines, 8(1), 1–9. https://doi.org/10.1038/s41541-023-00758-z Cite